FundingSenior Notes
IQVIA
IQVIA Holdings Inc. ('IQVIA') (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the 'Issuer'), priced an offering of €950,000,000 in aggregate principal amount of…
The North Carolina edition · 2026
North Carolina · Photo: Wikimedia Commons (CC BY-SA 3.0)Life sciencescompanies in North Carolina
Life science technology, genomics, oncology, medical devices, infectious disease and more: the companies building life sciences in North Carolina, with their founders, funding, team size and business models.
461 company profiles148 with recorded fundingNovember 2026 edition
Recent life sciences business events in North Carolina
Funding, M&A, contract wins and launches involving 700 life sciences companies in North Carolina, last 24 months: 39 funding rounds · 29 M&A deals · 18 Contracts · 1 Launch. Newest first; companies and investors link to their Fliar profiles. Latest event in our news feed: Jun 2026.
M&AAcquisition · Announced
Foundation medicine acquires Saga diagnostics
And with the $595 million acquisition of Saga Diagnostics announced last month, Roche subsidiary Foundation Medicine will gain a new tool in the disease monitoring market with the firm's…
Diagnostics
FundingStrategic investment
Ten63 therapeutics
Ten63 Therapeutics, an AI-driven drug discovery company, announced it has secured strategic investment from Chugai Venture Fund and the Gates Foundation, bringing its total funding to…
Biotechnology / Drug Discovery
M&AAcquisition · Announced
Biocryst pharmaceuticals acquires Astria therapeutics
At a special meeting held on January 21, 2026, Astria Therapeutics stockholders approved the company's acquisition by BioCryst Pharmaceuticals, with approximately 62.6% of outstanding…
Biopharmaceutical
FundingCredit Facility
Humacyte
Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company ... announced that it has entered into a credit facility with Avenue Venture Opportunities Fund II, L.P.,…
Investors Avenue Venture Opportunities Fund II, L.P.
Biotechnology
ContractTechnology
Ltimindtree · client: Convatec
LTIMindtree landed a contract with Convatec.
Healthcare
Contract
Dentsply sirona · client: Hobbs brook real estate
HBRE announced that Dentsply Sirona Inc., the world’s largest diversified manufacturer of professional dental products and technologies, has signed an 84,413-square-foot, six-year lease…
M&AAcquisition · Announced
Biocryst pharmaceuticals acquires Astria therapeutics
Sidley represented Astria Therapeutics, Inc., a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, in its definitive agreement…
Biopharmaceutical
ContractSupply
Polarean imaging · client: DK Healthcare
Durham, NC-based Polarean Imaging has signed an exclusive agreement with DK Healthcare to distribute its Xenon MRI platform in South Korea.
Medical Imaging
ContractService
Ltimindtree · client: Convatec
LTIMindtree [NSE: LTIM, BSE: 540005], a global technology consulting and digital solution company, has announced that it has been selected by Convatec, a world leader in medical products…
Healthcare
ContractSupply
BUILT Biotechnologies, Inc. · client: Neochromosome
BUILT Biotechnologies, Inc., an emerging leader in DNA Manufacturing-as-a-Service, today announced that it has been chosen as the preferred manufacturing partner for clients of…
Biotechnology
FundingRegistered direct offering
Humacyte
Humacyte Inc. (Nasdaq: HUMA) has priced a $60 million oversubscribed registered direct offering, reinforcing its liquidity position while igniting an investor debate over the trade-off…
Biotechnology
M&AAcquisition · Completed
Neopharmed gentili acquires Biocryst pharmaceuticals
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has successfully completed the previously announced sale of its European ORLADEYO business to Neopharmed Gentili.
Biotechnology
LaunchFulcrum
Pairwise
Pairwise’s flagship technology platform, Fulcrum, gives companies access to a suite of tools for using CRISPR gene‑editing to develop new crops and bring them to market faster than…
CRISPR gene‑editing platform
M&AAcquisition · Completed
Mars acquires Pairwise
Mars Incorporated, infatti, ha acquisito in licenza gli strumenti di editing genetico Fulcrum di Pairwise per la ricerca e lo sviluppo del cacao.
Genetic editing / Agriculture
ContractTechnology
Pairwise · client: Mars Inc.
The maker of Dove chocolate and M&M’s is entering into a licensing agreement with Pairwise, an agricultural gene editing firm, in order to accelerate the development of plants with…
Agriculture
FundingSenior Secured Credit Agreement
Bioventus
Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it has entered into a $400 million Senior Secured…
Healthcare
Funding
Liquidia technologies
On June 23, 2025, Liquidia Corporation announced receiving an additional $50 million in funding under its agreement with Healthcare Royalty Partners IV, following the first commercial…
Investors Healthcare Royalty Partners IV
Biopharmaceutical
FundingNon-dilutive funding
Opus genetics
Opus Genetics on Monday said it plans to advance its preclinical gene therapy program for retinitis pigmentosa caused by pathogenic variants in the MERTK gene toward clinical trials,…
Investors Retinal Degeneration (RD) Fund
Gene therapy, Ophthalmology
FundingSeries C
Genecentric therapeutics
GeneCentric Therapeutics announced Wednesday the initial closing of an $8 million Series C funding round to support the launch and commercialization of its GenomicsNext circulating tumor…
Investors Hatteras venture partners, Iag capital partners, Alexandria Venture Investments, Laboratory Corporation of America
Biotech
ContractInfrastructure
King Combs LLC · client: Liquidia technologies
On June 16, 2025, Liquidia Technologies entered into a lease agreement for a new manufacturing facility in Morrisville, North Carolina, with King Combs LLC.
M&AAcquisition · Announced
Janus Henderson acquires Tenax therapeutics
Janus Henderson Group PLC acquired a new stake in Tenax Therapeutics, Inc. (NASDAQ:TENX – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing…
M&AAcquisition · Completed
Captrust financial advisors acquires Biocryst pharmaceuticals
Captrust Financial Advisors increased its stake in shares of BioCryst Pharmaceuticals by 19.4% during the third quarter. Captrust Financial Advisors now owns 16,274 shares of the…
Biotechnology
M&AAcquisition · Completed
Arizona state retirement system acquires Biocryst pharmaceuticals
Arizona State Retirement System boosted its position in shares of BioCryst Pharmaceuticals by 6.6% in the 4th quarter. Arizona State Retirement System now owns 57,001 shares of the…
Biotechnology
M&AAcquisition · Completed
Sei investments acquires Biocryst pharmaceuticals
Sei Investments Co. grew its holdings in BioCryst Pharmaceuticals by 2.8% in the fourth quarter. Sei Investments Co. now owns 57,190 shares of the biotechnology company’s stock worth…
Biotechnology
M&AAcquisition · Completed
KLP Kapitalforvaltning AS acquires Biocryst pharmaceuticals
KLP Kapitalforvaltning AS acquired a new stake in shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) during the 4th quarter, according to its most recent disclosure…
Biotechnology
M&AAcquisition · Completed
SkyView Investment Advisors acquires Biocryst pharmaceuticals
SkyView Investment Advisors LLC lifted its holdings in shares of BioCryst Pharmaceuticals by 30.0% during the third quarter. SkyView Investment Advisors LLC now owns 13,000 shares of the…
Biotechnology
FundingSeries C
Atsena therapeutics
Atsena Therapeutics announced the successful close of an oversubscribed $150 million Series C financing.
Gene Therapy
FundingSeries A
Avalo
Avalo—a startup deploying interpretable artificial intelligence to develop climate resilient crops—has raised an $11 million Series A round
Investors Germin8 ventures, Alexandria Venture Investments, Coca-cola europacific partners, Trust ventures
AgTech / Agriculture
FundingPrivate placement
Tenax therapeutics
Tenax Therapeutics, Inc. (Nasdaq: TENX) announced that it has entered into a securities purchase agreement for a private placement financing with RTW Investments, which is expected to…
Investors Rtw investments
Pharmaceutical
Life sciences companies in North Carolina, by funding and team
Few life sciences companies in North Carolina publish revenue, so this list compares what is on record instead: recorded equity funding, team size, revenue model, age and stage. The 50 companies below lead on recorded funding and team size among 461 active companies.
Developer of therapeutics for eosinophilic asthma
PulmonologyUS$435.00mSeries A · Feb 2024
10LinkedIn · Jul 2026
E-commerce - product / Physical commerce
4 yr2022
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 19
- Recorded funding
- US$435.00m · Series A · Feb 2024
- Founded
- 2022 · about 4 years old
- Stage
- Series A
- Focus
- Drugs, Copd and asthma, Asthma
Funding over time
US$435.00m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Jorge BartolomeCEO
- Highest education
- Duke University
Investors · 10
Google VenturesFund
Marshall WaceFund
Maverick CapitalFund
- SanofiFund
Team & hiring signals
LinkedIn headcount1011-50
LinkedIn followers2,338
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of human tissue-based products for vascular disease
Regenerative medicineUS$424.76mSeries D · Jun 2018
159+71% 12 mo to Dec 2022LinkedIn · Oct 2026
Physical commerce
22 yr2004
0none in 3 months · last posted Mar 2026
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 70
- Recorded funding
- US$424.76m · Series D · Jun 2018
- Founded
- 2004 · about 22 years old
- Stage
- Public
- Focus
- Diversified, Drugs
Funding over time
US$424.76m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Juliana BlumCo-Founder, Executive Advisor
Investors · 7
Bangkok BankFund
Pacific EagleFund
Reignwood GroupFund- Brady DouganAngel
Team & hiring signals
LinkedIn headcount159201-500
LinkedIn followers16,756
Earlier recorded team702022, a different source
Open roles1of 3 tracked · last posted Mar 2026
LinkedIn page Patents
Patent filings137
Focus: Engineered vascular grafts and medicated implantable matrices for blood vessel replacement.
CPC C12N5/0068, A61F2/20, A61L27/3633Technology
AWS
PHP
MySQL
Nginx
WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of gene therapies for the treatment of ocular diseases
OphthalmologyUS$238.00mSeries C · Mar 2025
49-53% vs previous recordLinkedIn · Jul 2026
Fee-for-service
6 yr2020
0none in 3 months · last posted Jun 2026
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 23 (previous snapshot 49)
- Recorded funding
- US$238.00m · Series C · Mar 2025
- Founded
- 2020 · about 6 years old
- Stage
- Series C
- Focus
- Drugs, Retinal disorders
Funding over time
US$238.00m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Shannon BoyeFounder & Director
- Highest education
- Doctorates in neuroscience · University Of Florida
Investors · 11
AbingworthFund
Team & hiring signals
LinkedIn headcount4911-50
LinkedIn followers13,782
Earlier recorded team232022, a different source
Open roles1of 8 tracked · last posted Jun 2026
LinkedIn page Recent company signals
- Milestone first patient in Phase 3 pivotal cohort of the LIGHTHOUSE trial evaluating ATSN-201 for X-linked retinoschisis (#XLRS) patient doses
Technology
- PHP
- MySQL
Cloudflare- WordPress
jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of services in the development of precision medicine tools for cancer treatment
GenomicsUS$191.06mSeries D · Nov 2019
96-14% 12 mo to Dec 2022LinkedIn · Oct 2026
Fee-for-service
13 yr2013
0none in 3 months
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 993
- Recorded funding
- US$191.06m · Series D · Nov 2019
- Founded
- 2013 · about 13 years old
- Stage
- Public
- Focus
- Applied genomics, Clinical genomics, Diagnostics, Sequencing-based
Funding over time
US$191.06m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Sizhen WangCo-Founder & CEO
- Highest education
- Master's of business administration in finance · Ecole Des Hautes Etudes Commerciales
Investors · 11
AlexandriaFund
CICCFund
Share CapitalFund
V Star CapitalFund
Team & hiring signals
LinkedIn headcount96501-1,000
LinkedIn followers1,189
Earlier recorded team9932022, a different source
LinkedIn page Technology
- Nginx
Bootstrap- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of solutions for biomarker discovery, diagnostic tests and personalized medicine
Metabolic diseasesUS$165.87mSeries H · Dec 2024
203+20% 12 mo to Dec 2022LinkedIn · Jul 2026
Subscription
26 yr2000
0none in 3 months · last posted Apr 2026
SoftwareHas made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 189 (previous snapshot 311)
- Recorded funding
- US$165.87m · Series H · Dec 2024
- Founded
- 2000 · about 26 years old
- Stage
- Series H
- Focus
- In vitro diagnostic tests, Inborn errors of metabolism, Genomics research, Biomarker discovery
Funding over time
US$165.87m across 15 disclosed equity rounds
Darker bars = larger roundsFounders · 1
John RyalsEx-Founder
Investors · 12
- AlexandriaFund
Camden PartnersFund
- Fletcher SpaghtFund
Sevin RosenFund
The Aurora FundsFund
Team & hiring signals
LinkedIn headcount203201-500
LinkedIn followers22,872
Earlier recorded team1892022, a different source
Open roles4of 8 tracked · last posted Apr 2026
LinkedIn page Patents
Patent filings400
Focus: Metabolomics biomarker discovery and diagnostic assays for metabolic and inflammatory diseases
CPC G01N33/6893, G01N33/92, G01N33/6848Technology
- PHP
- MySQL
- Cloudflare
HubSpot
Salesforce
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Drug eluting coronary stent
Cardiac and vascular disordersUS$157.52mSeries D · Sep 2017
9-33% 12 mo to Dec 2020LinkedIn · Jul 2026
Subscription
31 yr1995
0none in 3 months
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 2 (previous snapshot 13)
- Recorded funding
- US$157.52m · Series D · Sep 2017
- Founded
- 1995 · about 31 years old
- Stage
- Series D
- Focus
- Medical devices, Therapeutic devices, Coronary and peripheral vascular diseases, Coronary artery diseases
Funding over time
US$157.52m across 11 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Arthur BenvenutoChairman & CEO
Investors · 3
- St. Jude MedicalFund
Team & hiring signals
LinkedIn headcount911-50
LinkedIn followers493
Earlier recorded team22020, a different source
LinkedIn page Patents
Patent filings363
Focus: Bioabsorbable polymer drug‑eluting coatings for stents and medical devices
CPC A61L31/16, A61F2/82, A61L31/10Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of gene editing technology for climate-resilient, nutritious, and sustainable crops
GenomicsUS$155.00mSeries C · Sep 2024
115+3% vs previous recordLinkedIn · Jul 2026
E-commerce - product / Physical commerce
9 yr2017
0none in 3 months · last posted Jun 2026
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 163 (previous snapshot 158)
- Recorded funding
- US$155.00m · Series C · Sep 2024
- Founded
- 2017 · about 9 years old
- Stage
- Series C
- Focus
- Applied genomics, Agrigenomics, Farm inputs, Seeds
Funding over time
US$155.00m across 3 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Tom AdamsCEO
Investors · 6
Aliment CapitalFund
DeerfieldFund
Leaps by BayerFund
MonsantoFund
TemasekFund
Team & hiring signals
LinkedIn headcount11551-200
LinkedIn followers18,199
Open roles1of 1 tracked · last posted Jun 2026
- Internship: 2026 Summer Intern
Recent company signals
- Partnership Partnership with Pipewise
Technology
- Cloudflare
- HubSpot
Webflow- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Clinical-stage pharmaceutical company focused on developing antibacterials
Infectious diseasesUS$149.50mSeries C · May 2010
11+44% 12 mo to Dec 2015LinkedIn · Oct 2026
E-commerce - product / Physical commerce
20 yr2006
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 78 (previous snapshot 16)
- Recorded funding
- US$149.50m · Series C · May 2010
- Founded
- 2006 · about 20 years old
- Stage
- Series C
- Focus
- Drugs, Bacterial, Drug resistant infections
Funding over time
US$149.50m across 5 disclosed equity rounds
Darker bars = larger roundsInvestors · 6
Aisling CapitalFund
Devon Park BioVenturesFund- Quaker PartnersFund
Team & hiring signals
LinkedIn headcount1151-200
LinkedIn followers2,054
Earlier recorded team782015, a different source
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of gene editing therapies to treat rare genetic diseases
Gene therapyUS$135.65mSeries B · Jun 2018
100+8% 12 mo to Dec 2022LinkedIn · Oct 2026
E-commerce - product / Physical commerce
20 yr2006
0none in 3 months · last posted Mar 2026
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 236
- Recorded funding
- US$135.65m · Series B · Jun 2018
- Founded
- 2006 · about 20 years old
- Stage
- Public
- Focus
- Enabling technologies, Technology platforms, Gene editing, Drugs
Funding over time
US$135.65m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Matthew KaneCEO
Investors · 20
Agent CapitalFund- Aliment CapitalFund
BaxterFund
CowenFund
Team & hiring signals
LinkedIn headcount10051-200
LinkedIn followers24,648
Earlier recorded team2362022, a different source
Open roles1of 1 tracked · last posted Mar 2026
LinkedIn page Patents
Patent filings68
Focus: Precise gene editing tools for therapeutic targets and engineered cell therapies
CPC C12N9/22, A61K38/465, C07K14/7151Technology
- AWS
- PHP
- MySQL
- Nginx
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of therapeutics for the treatment of migraine and other headache disorders
NeurologyUS$130.00mSeries A · Feb 2026
7LinkedIn · Jul 2026
E-commerce - product / Physical commerce
0 yr2026
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- Not available
- Recorded funding
- US$130.00m · Series A · Feb 2026
- Founded
- 2026 · about 0 years old
- Stage
- Series A
- Focus
- Drugs, Pain
Founders · 1
Neil BuckleyCo-Founder & CEO
- Highest education
- MS · Northeastern University
Investors · 3
ForbionFund
Foresite CapitalFund
Team & hiring signals
LinkedIn headcount72-10
LinkedIn followers1,001
LinkedIn page Recent company signals
- Leadership Hired a Chief Financial Officer
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of nasal based epinephrine for anaphylaxis
ImmunotherapyUS$127.68mSeries C · Apr 2025
4-9% vs previous recordLinkedIn · Jul 2026
E-commerce - product / Physical commerce
8 yr2018
0none in 3 months
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 10 (previous snapshot 11)
- Recorded funding
- US$127.68m · Series C · Apr 2025
- Founded
- 2018 · about 8 years old
- Stage
- Series C
- Focus
- Drugs, Allergies, Anaphylactic shock
Funding over time
US$127.68m across 6 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
David DworaczykRetired CEO: Corporate Advisor/Consultant to Bryn Pharma, LLC
- Highest education
- Doctorates, Leadership · University Of Delaware
Team & hiring signals
LinkedIn headcount42-10
LinkedIn followers2,269
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of therapeutics to treat cardiopulmonary diseases
Drug deliveryUS$126.60mSeries B · Nov 2023
17-6% vs previous recordrecorded
Fee-for-service
16 yr2010
—No postings tracked
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 17 (previous snapshot 18)
- Recorded funding
- US$126.60m · Series B · Nov 2023
- Founded
- 2010 · about 16 years old
- Stage
- Series B
- Focus
- Medical devices, Therapeutic devices, Drug delivery, Inhaled
Funding over time
US$126.60m across 12 disclosed equity rounds
Darker bars = larger roundsFounders · 1
John PattonFounder
Investors · 2
MolexFund
Molex VenturesFund
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Targeted drug delivery platforms optimizing neurological disorder treatment and patient outcomes
Drug deliveryUS$119.30mSeries B · Jan 2021
16-16% 12 mo to Dec 2020LinkedIn · Oct 2026
E-commerce - product / Physical commerce
21 yr2005
0none in 3 months
SoftwareHardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 72
- Recorded funding
- US$119.30m · Series B · Jan 2021
- Founded
- 2005 · about 21 years old
- Stage
- Series B
- Focus
- Implants
Funding over time
US$119.30m across 8 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Steve AdlerCEO
Investors · 4
BlackstoneFund
Elevage CapitalFund
Hercules CapitalFund
Team & hiring signals
LinkedIn headcount1651-200
LinkedIn followers6,224
Earlier recorded team722020, a different source
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of drug discovery and precision therapy platform for oncology
OncologyUS$116.26mSeries B · Apr 2025
10LinkedIn · Jul 2026
Subscription
7 yr2019
0none in 3 months · last posted Jul 2025
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 72
- Recorded funding
- US$116.26m · Series B · Apr 2025
- Founded
- 2019 · about 7 years old
- Stage
- Series B
- Focus
- Research assays, Drug discovery, Organoid models, Patient derived cancer cell models
Funding over time
US$116.26m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Hans CleversCo-Founder
Investors · 14
- AlexandriaFund
Alix VenturesFund
- Duke UniversityFund
EQTFund
FPV VenturesFund
Felicis VenturesFund
Team & hiring signals
LinkedIn headcount1051-200
LinkedIn followers7,314
Open roles0of 2 tracked · last posted Jul 2025
LinkedIn page Patents
Patent filings97
Focus: Microfluidic organoid droplet generation and component delivery for personalized medicine
CPC B01L3/502784, C12N5/0693, G01N33/5011Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of Nitric Oxide based therapeutics for dermatology disorders
DermatologyUS$112.84mSeries C · Dec 2015
105+178% 12 mo to Dec 2022LinkedIn · Oct 2026
Physical commerce
20 yr2006
0none in 3 months
Has made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 89 (previous snapshot 60)
- Recorded funding
- US$112.84m · Series C · Dec 2015
- Founded
- 2006 · about 20 years old
- Stage
- Public
- Focus
- Drugs, Viral, Hpv, Diversified
Funding over time
US$112.84m across 6 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Paula Brown StaffordCEO & President
- Highest education
- Bachelor's in public health · University Of North Carolina At Chapel Hill
Investors · 2
Malin PLCFund- John PalmourAngel
Team & hiring signals
LinkedIn headcount10551-200
LinkedIn followers4,292
Earlier recorded team892022, a different source
LinkedIn page Recent company signals
- Milestone member of Russell 3000ETM Growth Benchmark, Russell Microcap®, and Russell Microcap® Growth Benchmark Indexes growth Benchmark, Russell Micr
Patents
Patent filings227
Focus: Topical pharmaceutical formulations for nitric‑oxide, antiviral, and wound‑healing applications
CPC A61K9/0014, A61K33/00, A61K31/695Technology
- PHP
- MySQL
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of healthcare solutions
DermatologyUS$106.25mSeries E · Apr 2020
76+27% vs previous recordLinkedIn · Oct 2026
E-commerce - product
19 yr2007
0none in 3 months · last posted Dec 2025
Consumer
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product
- Team size
- 94 (previous snapshot 74)
- Recorded funding
- US$106.25m · Series E · Apr 2020
- Founded
- 2007 · about 19 years old
- Stage
- Series E
- Focus
- Drugs, Muscle disorders, Diversified
Funding over time
US$106.25m across 45 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Steve WoodyCEO & Director
- Highest education
- Bachelor's Of Science · UNC Asheville
Team & hiring signals
LinkedIn headcount7651-200
LinkedIn followers1,921
Open roles1of 2 tracked · last posted Dec 2025
- Hiring: Accounts Receivable / Accounts Payable Manager · Charlotte, North Carolina
- Hiring: Arcs Receivable / Accounts Payable Manager · Swannanoa or Charlotte, NC area
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of AAV based gene therapies for rare diseases
GenomicsUS$98.20mSeries B · Mar 2021
4+82% 12 mo to Dec 2022LinkedIn · Oct 2026
Subscription
11 yr2015
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 109 (previous snapshot 120)
- Recorded funding
- US$98.20m · Series B · Mar 2021
- Founded
- 2015 · about 11 years old
- Stage
- Series B
- Focus
- Drugs, Diversified, Enabling technologies, Technology platforms
Funding over time
US$98.20m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 3
Aravind AsokanCo-Founder
- Highest education
- Virology · University Of North Carolina At Chapel Hill School Of Medicine
Mavis Agbandje-McKennaCo-Founder & Director
Patrick RitschelCo-Founder
- Highest education
- Bachelor's in mechanical engineering · University Of Illinois At Urbana - Champaign
Investors · 12
- AlexandriaFund
- Novo HoldingsFund
PontifaxFund
SareptaFund
Team & hiring signals
LinkedIn headcount451-200
LinkedIn followers5,067
Earlier recorded team1092022, a different source
LinkedIn page Patents
Patent filings89
Focus: Recombinant AAV vector design, manufacturing, and gene‑therapy delivery platforms
CPC C12N15/86, C07K14/005, C07K14/47Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of diagnostic products for pediatrics
PediatricsUS$95.89mSeries C · Sep 2025
73+51% 12 mo to Dec 2022LinkedIn · Jul 2026
Subscription
13 yr2013
0none in 3 months · last posted Nov 2025
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 133
- Recorded funding
- US$95.89m · Series C · Sep 2025
- Founded
- 2013 · about 13 years old
- Stage
- Series C
- Focus
- In vitro diagnostic tests, Newborn genetic screening
Funding over time
US$95.89m across 6 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Richard WestCo-Founder & CEO
- Highest education
- Doctorates in management · Claremont Graduate University
Vamsee PamulaFounder and President, Board of Directors
Investors · 5
- Duke UniversityFund
Team & hiring signals
LinkedIn headcount7351-200
LinkedIn followers6,898
Earlier recorded team1332022, a different source
Open roles1of 1 tracked · last posted Nov 2025
LinkedIn page Patents
Patent filings56
Focus: Rapid microfluidic PCR and point‑of‑care diagnostic platforms for biochemical assays
CPC G01N33/54366, B01L7/525, G01N33/4905Technology
React- PHP
- MySQL
- Cloudflare
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of therapeutics for pulmonary hypertension and cardiopulmonary conditions
NanotechnologyUS$90.30mSeries D · Feb 2018
300+0% 12 mo to Dec 2022LinkedIn · Oct 2026
E-commerce - product / Physical commerce
22 yr2004
0none in 3 months · last posted Jun 2026
Has made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 63
- Recorded funding
- US$90.30m · Series D · Feb 2018
- Founded
- 2004 · about 22 years old
- Stage
- Public
- Focus
- Nanoparticle based, Nanoenabled products, Life science, Drug delivery
Funding over time
US$75.30m across 5 disclosed equity rounds
Darker bars = larger roundsInvestors · 11
AmereusFund
CanaanFund
Firelake CapitalFund
MorningsideFund
Next47Fund
Pappas CapitalFund
Team & hiring signals
LinkedIn headcount30051-200
LinkedIn followers15,200
Earlier recorded team632022, a different source
Open roles3of 9 tracked · last posted Jun 2026
- Hiring: Territory Account Manager · New York City Metropolitan Area
- Hiring: Lead IT Systems Administrator · Morrisville, North Carolina
- Hiring: Sr. Scientist, Quality Control · Morrisville, North Carolina
Patents
Patent filings120
Focus: Patents concentrated in transport & manufacturing processes
CPC B29C33/3857, B29C35/0805, A61N1/306Technology
- AWS
- PHP
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of therapeutics for infectious disease and inflammatory indications
Infectious diseasesUS$67.33mSeries B · May 2022
55-1% 12 mo to Dec 2022LinkedIn · Oct 2026
E-commerce - product / Physical commerce
11 yr2015
0none in 3 months · last posted Aug 2025
Has made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 74 (previous snapshot 104)
- Recorded funding
- US$67.33m · Series B · May 2022
- Founded
- 2015 · about 11 years old
- Stage
- Series B
- Focus
- Enabling technologies, Technology platforms, Gene editing, Drugs
Funding over time
US$67.33m across 5 disclosed equity rounds
Darker bars = larger roundsInvestors · 7
Artis VenturesFund
IlluminaFund
NCBiotechFund
TencentFund
Team & hiring signals
LinkedIn headcount5551-200
LinkedIn followers9,083
Earlier recorded team742022, a different source
Open roles0of 3 tracked · last posted Aug 2025
LinkedIn page Recent company signals
- Partnership Partnership with Viatris
Patents
Patent filings60
Focus: Engineered CRISPR‑enhanced bacteriophage therapeutics targeting antibiotic‑resistant bacterial infections
CPC C12N15/74, A61K35/76, C12N7/00Technology
- PHP
- MySQL
- Nginx
- Cloudflare
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of vascular stenting with embolic protection for both coronary and peripheral vasculature
Cardiac and vascular disordersUS$66.01mSeries D · Apr 2023
50+38% vs previous recordLinkedIn · Jul 2026
Physical commerce
21 yr2005
0none in 3 months
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 33 (previous snapshot 24)
- Recorded funding
- US$66.01m · Series D · Apr 2023
- Founded
- 2005 · about 21 years old
- Stage
- Series D
- Focus
- Medical devices, Therapeutic devices, Coronary and peripheral vascular diseases, Diversified
Funding over time
US$66.01m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Ravish SacharFounder & CEO
- Highest education
- Doctor of Medicine · Columbia University
Investors · 9
Lookout CapitalFund
MedtronicFund
- NCBiotechFund
Team & hiring signals
LinkedIn headcount5011-50
LinkedIn followers3,071
LinkedIn page Technology
- PHP
- MySQL
- Cloudflare
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of rapid infusion system for critically ill patients
Hospital equipmentUS$65.98mSeries B · Mar 2025
61-6% vs previous recordLinkedIn · Jul 2026
Subscription
14 yr2012
0none in 3 months
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 33 (previous snapshot 35)
- Recorded funding
- US$65.98m · Series B · Mar 2025
- Founded
- 2012 · about 14 years old
- Stage
- Series B
- Focus
- Critical care, Infusion systems
Funding over time
US$65.98m across 8 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Mark PiehlCo-Founder & CMO
- Highest education
- Medicine · University Of North Carolina At Chapel Hill School Of Medicine
Investors · 13
OSF HealthCareFund
Orlando HealthFund
WakeMedFund
WellStarFund
Team & hiring signals
LinkedIn headcount6111-50
LinkedIn followers8,431
LinkedIn page Technology
- PHP
- MySQL
- Cloudflare
- HubSpot
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider RNA-targeted drug discovery platform
GenomicsUS$65.30mSeries A · Sep 2019
21-41% 12 mo to Dec 2022LinkedIn · Jul 2026
Subscription
10 yr2016
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 26 (previous snapshot 34)
- Recorded funding
- US$65.30m · Series A · Sep 2019
- Founded
- 2016 · about 10 years old
- Stage
- Series A
- Focus
- Applied genomics, Clinical genomics, Therapeutics, Research assays
Funding over time
US$65.30m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Katie WarnerCo-Founder
Investors · 12
AbbVieFund- AlexandriaFund
M VenturesFund
- Pappas CapitalFund
Team & hiring signals
LinkedIn headcount2111-50
LinkedIn followers3,907
Earlier recorded team262022, a different source
LinkedIn page Patents
Patent filings9
Focus: eIF4E inhibitor small molecules for oncology therapeutics
CPC C07D239/90, C07D471/04, A61P35/00Technology
- AWS
- PHP
- MySQL
- Nginx
- Cloudflare
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of viral vaccines and antibody drug conjugates for the treatment of cancer
ImmunotherapyUS$48.59mSeries B · Apr 2021
4+34% 12 mo to Dec 2021LinkedIn · Jul 2026
E-commerce - product / Physical commerce
12 yr2014
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 47 (previous snapshot 56)
- Recorded funding
- US$48.59m · Series B · Apr 2021
- Founded
- 2014 · about 12 years old
- Stage
- Series B
- Focus
- Drugs, Diversified, Viral
Funding over time
US$48.59m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Matthias GromeierFounder
Darell BignerFounder
Team & hiring signals
LinkedIn headcount42-10
LinkedIn followers3,393
Earlier recorded team472021, a different source
LinkedIn page Patents
Patent filings7
Focus: Oncolytic chimeric poliovirus therapies for glioblastoma and intravesical bladder cancer treatment
CPC A61K35/768, A61P35/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Clinical-stage biopharmaceutical company developing novel medicines for autoimmune and inflammatory diseases
Imaging diagnosticsUS$48.58mSeries B · Oct 2018
—Not available
E-commerce - product / Physical commerce
14 yr2012
—No postings tracked
Acquirer · 2 deals
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- Not available
- Recorded funding
- US$48.58m · Series B · Oct 2018
- Founded
- 2012 · about 14 years old
- Stage
- Series B
- Focus
- Drugs, Diversified, Accessories, Radioisotopes
Funding over time
US$48.58m across 7 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Chris Priorex-CEO
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
A next-generation cell cycle control company advancing precision treatments for cancer
ImmunotherapyUS$46.25mSeries B · Apr 2026
13+0% vs previous recordLinkedIn · Jul 2026
Physical commerce
6 yr2020
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 6 (previous snapshot 6)
- Recorded funding
- US$46.25m · Series B · Apr 2026
- Founded
- 2020 · about 6 years old
- Stage
- Series B
- Focus
- Drugs, Diversified
Funding over time
US$46.25m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 4
Patrick RobertsCo-Founder & CEO
- Highest education
- The University of North Carolina
Jay StrumCo-Founder
- Highest education
- PhD · Wake Forest University
John BisiCo-Founder
- Highest education
- Bachelor's of Science · NC State University
Fred EshelmanCo-Founder
Investors · 7
- Boxer CapitalFund
LillyFund- PharmacosmosFund
Team & hiring signals
LinkedIn headcount132-10
LinkedIn followers1,691
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Manufacturer of cytokine agents for treating cancer
ImmunotherapyUS$45.00mSeries A · Nov 2020
47+34% 12 mo to Dec 2021recorded Dec 2021
Fee-for-service
7 yr2019
0none in 3 months
Has made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 47 (previous snapshot 47)
- Recorded funding
- US$45.00m · Series A · Nov 2020
- Founded
- 2019 · about 7 years old
- Stage
- Series A
- Focus
- Drugs, Diversified
Leadership · 1
Charles NicoletteCEO
Investors · 1
- Lucio RovatiAngel
Patents
Patent filings55
Focus: Patents concentrated in chemistry & materials
CPC C12N5/0639, G01N33/56972, C12N9/0002Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Affordable prescription drugs online, bridging the gap for US customers
OncologyUS$42.10mSeries D · Jul 2017
1-10% 12 mo to Dec 2022LinkedIn · Jul 2026
Physical commerce
12 yr2014
0none in 3 months
ConsumerSocial impact
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 19
- Recorded funding
- US$42.10m · Series D · Jul 2017
- Founded
- 2014 · about 12 years old
- Stage
- Series D
- Focus
- Drugs, Pan cancer
Funding over time
US$42.10m across 3 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Fred EshelmanCEO
Investors · 6
Lilly VenturesFund
- Fred EshelmanAngel
Team & hiring signals
LinkedIn headcount12-10
LinkedIn followers341
Earlier recorded team192022, a different source
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of pulmonary drug delivery solutions
PulmonologyUS$42.00mSeries B · Feb 2025
12LinkedIn · Jul 2026
E-commerce - product / Physical commerce
11 yr2015
—No postings tracked
Consumer
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- Not available
- Recorded funding
- US$42.00m · Series B · Feb 2025
- Founded
- 2015 · about 11 years old
- Stage
- Series B
- Focus
- Medical devices, Therapeutic devices, Drug delivery
Funding over time
US$42.00m across 7 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Eric HunterCEO
Investors · 1
Team & hiring signals
LinkedIn headcount1211-50
LinkedIn followers340
LinkedIn page Patents
Patent filings237
Focus: Advanced aerosol and droplet drug delivery systems for respiratory and nasal therapeutics
CPC A61M15/0085, A61M11/005, A61M11/003Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developing an inhaled approach to treat lung disease with excess mucus and mucus plugs
PulmonologyUS$41.00mSeries A · Jan 2025
10+14% vs previous recordLinkedIn · Jul 2026
Physical commerce
12 yr2014
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 8 (previous snapshot 7)
- Recorded funding
- US$41.00m · Series A · Jan 2025
- Founded
- 2014 · about 12 years old
- Stage
- Series A
- Focus
- Drugs, Lung infections
Funding over time
US$41.00m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
John FahyFounder
- Highest education
- Master's of Science · Trinity College Dublin
Investors · 3
Team & hiring signals
LinkedIn headcount102-10
LinkedIn followers1,199
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of based medical sensors for monitoring body vitals
SensorsUS$37.60mSeries E · Jan 2020
34+6% 12 mo to Dec 2022recorded Dec 2022
Subscription
20 yr2006
0none in 3 months
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 34 (previous snapshot 42)
- Recorded funding
- US$37.60m · Series E · Jan 2020
- Founded
- 2006 · about 20 years old
- Stage
- Series E
- Focus
- Technology enablers, Sensors, Generic sensor developers, Biological
Funding over time
US$37.60m across 6 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Steven LeboeufPresident & Co-Founder
- Highest education
- Doctorates in electrical engineering · North Carolina State University
Investors · 7
Best BuyFund
SonionFund
TDF VenturesFund
True VenturesFund
HalmaFund
Patents
Patent filings418
Focus: Wearable photoplethysmography sensors for real-time health metrics estimation
CPC A61B5/0205, A61B5/02055, A61B5/721Technology
Vue.js- Cloudflare
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of thymus-based therapies for immune-mediated diseases to increase healthspan
ImmunologyUS$37.40mSeed · Dec 2024
16LinkedIn · Jul 2026
Subscription
3 yr2023
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$37.40m · Seed · Dec 2024
- Founded
- 2023 · about 3 years old
- Stage
- Seed
- Focus
- Diversified, Drugs
Funding over time
US$37.40m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Holger RussScientific Co-Founder
- Highest education
- Doctorates in philosophy · Tel Aviv University
Francisco LeonFounder,& CEO, Chairman
Investors · 6
BioAdvanceFund
Columbus Venture PartnersFund- Sessa CapitalFund
Team & hiring signals
LinkedIn headcount162-10
LinkedIn followers2,283
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of sleep management systems
Disease self managementUS$37.00mSeries C · Dec 2020
23-51% 12 mo to Dec 2023LinkedIn · Jul 2026
Subscription
19 yr2007
0none in 3 months
ConsumerSoftwareHardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 21 (previous snapshot 54)
- Recorded funding
- US$37.00m · Series C · Dec 2020
- Founded
- 2007 · about 19 years old
- Stage
- Series C
- Focus
- Sleep, Monitoring, Quality of sleep, Device
Founders · 2
Tara YoungbloodCo-Founder & VP
- Highest education
- Mathematics · Principia College
Todd YoungbloodCo-Founder
- Highest education
- Bachelor's of Arts · Principia College
Investors · 1
KKRFund
Team & hiring signals
LinkedIn headcount2311-50
LinkedIn followers1,722
Earlier recorded team212023, a different source
LinkedIn page Recent company signals
- Expansion transitioned manufacturing and assembly operations from overseas to new facility in Mooresville, NC
Patents
Patent filings31
Focus: Smart therapeutic bedding systems for stress reduction, sleep enhancement, and weight‑loss support
CPC A47C21/04, A61M21/02, A61B5/4815Mobile apps
- ChilipadHealth & Fitness · 15,322 installs · ★ 2.1 · updated 2026-05-25
Technology
- AWS
- Vue.js
- Cloudflare
- Segment
Zendesk
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of therapeutic products to treat brain injury in children
PediatricsUS$37.00mSeries A · Dec 2022
5-20% vs previous recordLinkedIn · Jul 2026
E-commerce - product / Physical commerce
8 yr2018
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 8 (previous snapshot 10)
- Recorded funding
- US$37.00m · Series A · Dec 2022
- Founded
- 2018 · about 8 years old
- Stage
- Series A
- Focus
- Drugs, White matter brain injury
Funding over time
US$37.00m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Eric BennerCo-Founder
- Highest education
- Duke University School Of Medicine
Jason KralicCo-Founder
- Highest education
- Doctorates in neuroscience · University Of North Carolina At Chapel Hill School Of Medicine
Investors · 1
XontogenyFund
Team & hiring signals
LinkedIn headcount52-10
LinkedIn followers1,105
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of urological devices for post-prostatectomy
Genitourinary disordersUS$36.15mSeries B · Feb 2026
8LinkedIn · Jul 2026
Physical commerce / Subscription
5 yr2021
0none in 3 months
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce, Subscription
- Team size
- 3 (previous snapshot 3)
- Recorded funding
- US$36.15m · Series B · Feb 2026
- Founded
- 2021 · about 5 years old
- Stage
- Series B
- Focus
- Medical devices, Therapeutics, Urinary incontinence
Funding over time
US$36.15m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Bruce ChoiFounder & CTO
- Highest education
- Master's of science in biomedical engineering · California Polytechnic State University - San Luis Obispo
Team & hiring signals
LinkedIn headcount82-10
LinkedIn followers1,183
LinkedIn page Recent company signals
- Milestone first patient enrolled in the ARID II IDE pivotal trial
- Milestone 17th site to enroll a patient into the study patient enrollment site enrollment
- Milestone 16th site to enroll a patient into the study patient enrollment site enrollment
- Milestone 15th site to enroll a patient into the study patient enrollment site enrollment
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of therapeutics for neurodegenerative diseases
NeurologyUS$33.02mSeries B · Sep 2022
12-12% vs previous recordLinkedIn · Jul 2026
E-commerce - product / Physical commerce
13 yr2013
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 14 (previous snapshot 16)
- Recorded funding
- US$33.02m · Series B · Sep 2022
- Founded
- 2013 · about 13 years old
- Stage
- Series B
- Focus
- Drugs, Neurodegenerative, Alzheimer disease
Funding over time
US$33.02m across 8 disclosed equity rounds
Darker bars = larger roundsFounders · 1
John DidsburyFounder and CEO
Investors · 1
NIAFund
Team & hiring signals
LinkedIn headcount122-10
LinkedIn followers472
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of an proprietary oral testosterone replacement therapy platform
Women healthUS$32.61mSeries B · Oct 2021
26LinkedIn · Jul 2026
E-commerce - product / Physical commerce
9 yr2017
0none in 3 months · last posted Jan 2026
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 20
- Recorded funding
- US$32.61m · Series B · Oct 2021
- Founded
- 2017 · about 9 years old
- Stage
- Series B
- Focus
- Drugs
Funding over time
US$11.61m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Himanshu ShahCo-Founder
Investors · 1
Shah CapitalFund
Team & hiring signals
LinkedIn headcount2611-50
LinkedIn followers3,424
Open roles3of 5 tracked · last posted Jan 2026
LinkedIn page Recent company signals
- Partnership Partnership with Hikma Pharmaceuticals
Technology
- PHP
- MySQL
- Cloudflare
- HubSpot
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of hemostasis and fluid replacement products
HematologyUS$30.45mSeries B · Jul 2022
12-20% 12 mo to Dec 2020LinkedIn · Jul 2026
Subscription
24 yr2002
0none in 3 months
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 4 (previous snapshot 12)
- Recorded funding
- US$30.45m · Series B · Jul 2022
- Founded
- 2002 · about 24 years old
- Stage
- Series B
- Focus
- Medical devices, Monitoring, Coagulation
Funding over time
US$30.45m across 9 disclosed equity rounds
Darker bars = larger roundsLeadership · 2
John MowellCEO - Chairman
Bert ValadaPresident and CEO
Team & hiring signals
LinkedIn headcount122-10
LinkedIn followers509
Earlier recorded team42020, a different source
LinkedIn page Patents
Patent filings112
Focus: Hemostatic textiles and point‑of‑care coagulation monitoring devices for surgical bleeding control
CPC G01N33/86, A61L15/00, A61K9/1688Technology
- Cloudflare
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of intraoral 3D Tomosynthesis dental X-ray system
Imaging diagnosticsUS$29.70mSeries B · Jun 2023
19recorded
Physical commerce
11 yr2015
0none in 3 months
SoftwareHardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 19
- Recorded funding
- US$29.70m · Series B · Jun 2023
- Founded
- 2015 · about 11 years old
- Stage
- Series B
- Focus
- Medical devices, Screening devices, X ray, Provider
Funding over time
US$29.70m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
David VanceCEO
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developing inhaled therapeutics for severe, chronic respiratory diseases
PulmonologyUS$29.12mSeries A · Oct 2018
10recorded
Physical commerce
13 yr2013
—No postings tracked
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 10
- Recorded funding
- US$29.12m · Series A · Oct 2018
- Founded
- 2013 · about 13 years old
- Stage
- Series A
- Focus
- Drugs, Diversified
Funding over time
US$29.12m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Robert Tarranex-Co-Founder
- Highest education
- PhD · Newcastle University
Investors · 3
5AM VenturesFund- CanaanFund
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Minimally-invasive prostate treatment using HIFU technology for precision prostate care
Surgical instrumentsUS$29.02mSeries B · Jul 2010
80-14% 12 mo to Dec 2022LinkedIn · Jul 2026
E-commerce - product / Physical commerce
22 yr2004
0none in 3 months
SoftwareHardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 38 (previous snapshot 93)
- Recorded funding
- US$29.02m · Series B · Jul 2010
- Founded
- 2004 · about 22 years old
- Stage
- Series B
- Focus
- Cutting and ablating
Funding over time
US$29.02m across 3 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
MARK CAROLCEO & President
Investors · 2
Galen PartnersFund
MMV FinancialFund
Team & hiring signals
LinkedIn headcount8051-200
LinkedIn followers13,504
Earlier recorded team382022, a different source
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
The company provides a full-stack clinical trials platform for community physicians
Life sciences techUS$27.50mSeries A · Jan 2022
30-65% vs previous recordLinkedIn · Jul 2026
Subscription
6 yr2020
0none in 3 months · last posted Jan 2026
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 12 (previous snapshot 34)
- Recorded funding
- US$27.50m · Series A · Jan 2022
- Founded
- 2020 · about 6 years old
- Stage
- Series A
- Focus
- Training platforms, Clinical research
Funding over time
US$27.50m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 3
Andrew KirchnerCo-Founder
- Highest education
- Doctor of jurisprudence in law · Columbia Law School
Alexander Saint-AmandCo-Founder & CEO
- Highest education
- Bachelor's of Arts · University of Virginia
Mac ParishCo-Founder, Product
- Highest education
- Master's of business administration · Stanford University Graduate School Of Business
Investors · 5
- Spencer RascoffAngel
- Tom LeeAngel
- Bobby GreenAngel
Team & hiring signals
LinkedIn headcount3051-200
LinkedIn followers5,184
Earlier recorded team122021, a different source
Open roles2of 11 tracked · last posted Jan 2026
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Provider of creatine monohydrate gummies to support overall well-being
Nutraceuticals techUS$27.33mSeries B · Mar 2026
57LinkedIn · Jul 2026
E-commerce - product
4 yr2022
0none in 3 months · last posted Apr 2026
Consumer
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product
- Team size
- 8
- Recorded funding
- US$27.33m · Series B · Mar 2026
- Founded
- 2022 · about 4 years old
- Stage
- Series B
- Focus
- Supplements, Multicategory, Gummies
Funding over time
US$27.33m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Sienna McCormickCo-Founder & Co-CEO
- Highest education
- Bachelor's of Arts - BA, Economics, Finance, and Chinese · Georgetown University
Daniel McCormickCo-Founder & CEO
- Highest education
- Georgetown University
Investors · 3
ACGFund- Impact CapitalFund
Team & hiring signals
LinkedIn headcount5711-50
LinkedIn followers10,170
Open roles5of 11 tracked · last posted Apr 2026
LinkedIn page Recent company signals
- Launch Launched Single Serve daily pouches (three gummies, one pouch) (creatine + Electrolytes sticks)
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Online platform for analyzing omics clinical data
Life sciences techUS$27.28mSeries A · May 2024
27-43% vs previous recordLinkedIn · Jul 2026
Subscription
5 yr2021
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 21 (previous snapshot 37)
- Recorded funding
- US$27.28m · Series A · May 2024
- Founded
- 2021 · about 5 years old
- Stage
- Series A
- Focus
- Research & development, Drug informatics, Clinical data analysis, Omics analysis
Funding over time
US$27.28m across 2 disclosed equity rounds
Darker bars = larger roundsInvestors · 3
Anzu PartnersFund
Genoa VenturesFund
VC23Fund
Team & hiring signals
LinkedIn headcount2711-50
LinkedIn followers2,217
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of diagnostics for cancer classification and treatment
GenomicsUS$26.86mSeries C · Jun 2025
14-14% vs previous recordLinkedIn · Jul 2026
Subscription
15 yr2011
0none in 3 months
Has made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 19 (previous snapshot 22)
- Recorded funding
- US$26.86m · Series C · Jun 2025
- Founded
- 2011 · about 15 years old
- Stage
- Series C
- Focus
- Applied genomics, Clinical genomics, Therapeutics, In-vitro diagnostic tests
Funding over time
US$26.86m across 5 disclosed equity rounds
Darker bars = larger roundsInvestors · 5
- AlexandriaFund
LabCorpFund
Alexandria Venture InvestmentsFund
Team & hiring signals
LinkedIn headcount1411-50
LinkedIn followers2,216
LinkedIn page Technology
- PHP
- MySQL
- Cloudflare
- Salesforce
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Restoring lung health through innovative therapies for chronic respiratory diseases
PulmonologyUS$25.83mSeries B · Mar 2023
6LinkedIn · Jul 2026
Fee-for-service
13 yr2013
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 6
- Recorded funding
- US$25.83m · Series B · Mar 2023
- Founded
- 2013 · about 13 years old
- Stage
- Series B
- Focus
- Drugs, Diversified
Funding over time
US$25.83m across 5 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Dan CopelandCEO
- Highest education
- BA · The University of Texas at Austin
Investors · 1
Team & hiring signals
LinkedIn headcount62-10
LinkedIn followers457
LinkedIn page Patents
Patent filings66
Focus: Antioxidant pharmaceutical formulations using vitamin C and glutathione for respiratory therapies
CPC A61K38/063, A61K9/08, A61P11/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of gene therapies to treat retinal degenerative diseases
Gene therapyUS$23.50mSeed · Jun 2023
46-55% vs previous recordLinkedIn · Oct 2026
Fee-for-service
5 yr2021
0none in 3 months · last posted Mar 2026
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 14 (previous snapshot 31)
- Recorded funding
- US$23.50m · Seed · Jun 2023
- Founded
- 2021 · about 5 years old
- Stage
- Public
- Focus
- Drugs, Retinal disorders
Funding over time
US$23.50m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Jason MenzoCo-Founder
Investors · 3
Bios PartnersFund
RD FundFund
Team & hiring signals
LinkedIn headcount4611-50
LinkedIn followers9,127
Open roles1of 2 tracked · last posted Mar 2026
LinkedIn page Patents
Patent filings26
Focus: Pharmaceutical eye‑drop formulations targeting mydriasis, presbyopia, and AMD treatment
CPC A61K31/417, A61K9/0048, C07C57/42Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- Bootstrap
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of boron-based medicines for various disease conditions
Life sciences techUS$23.50mSeries A · Sep 2022
2LinkedIn · Jul 2026
Commission on transaction / E-commerce - product
5 yr2021
0none in 3 months
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Commission on transaction, E-commerce - product, Subscription
- Team size
- Not available
- Recorded funding
- US$23.50m · Series A · Sep 2022
- Founded
- 2021 · about 5 years old
- Stage
- Series A
- Focus
- Research & development, Drug discovery, Cheminformatics, Lead discovery
Leadership · 1
Julie GrantCEO
- Highest education
- MBA · Stanford University
Team & hiring signals
LinkedIn headcount211-50
LinkedIn followers467
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of a technology to isolate and recover single cells for molecular analysis
Life sciences platforms and toolsUS$19.10mSeries B · Aug 2023
21+4% vs previous recordLinkedIn · Jul 2026
Subscription
17 yr2009
0none in 3 months
HardwareHas made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 28 (previous snapshot 27)
- Recorded funding
- US$19.10m · Series B · Aug 2023
- Founded
- 2009 · about 17 years old
- Stage
- Series B
- Focus
- Instruments, Cell biology, Cell sorting
Funding over time
US$19.10m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Gary PaceCEO
Investors · 2
Team & hiring signals
LinkedIn headcount2111-50
LinkedIn followers2,101
LinkedIn page Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Developer of integrated 3D printing and tissue-engineering platform
3d printingUS$19.00mSeries B · Jan 2024
43+100% 12 mo to Dec 2022LinkedIn · Jul 2026
Physical commerce / Subscription
11 yr2015
0none in 3 months
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce, Subscription
- Team size
- 6 (previous snapshot 31)
- Recorded funding
- US$19.00m · Series B · Jan 2024
- Founded
- 2015 · about 11 years old
- Stage
- Series B
- Focus
- Medical devices, Therapeutic devices, Heart attack, Instruments
Founders · 3
Shay SokerCo-Founder & CSO
Aryeh BattCo-Founder & CEO
- Highest education
- Physics · Lev Academic Center (Jct) (Jerusalem College Of Technology )
Anthony AtalaCo-Founder & CMO
Investors · 2
ZEISSFund
Aurum VenturesFund
Team & hiring signals
LinkedIn headcount4311-50
LinkedIn followers3,958
Earlier recorded team62022, a different source
LinkedIn page Recent company signals
- Milestone first public presentation in Europe of clinical data from AECOS Madrid program
Technology
- PHP
- MySQL
- Nginx
- WordPress
- Bootstrap
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
No matching company in this list.
50 of 461 companies shown here · the full list is on Radar
Fliar Radar
Explore all 461 life sciences companies in North Carolina on Radar
This page shows the top 50. Radar has the complete, filterable list with contacts and live company signals.
Open life sciences in North Carolina on Radar- Every company, not just 50All 461 life sciences companies in North Carolina, filterable by stage, funding, team size, revenue model and age.
- Founders and decision-makersLeadership teams with roles and verified LinkedIn profiles, ready for outreach.
- Live signalsFunding rounds, hiring, launches and M&A as they happen, with alerts on the companies you follow.
- Save and exportBuild lists, compare companies side by side and export them from your Radar account.
Explore life sciences companies in North Carolina by what you are looking for
Find top life sciences companies in North Carolina for research, drug development and medical technology. Browse life sciences companies and life sciences jobs across North Carolina.
8 ways to explore life sciences in North Carolina
Life sciences technology and research platformsGenomics and gene therapy companiesOncology and immunotherapy companiesMedical device and orthopedic companiesInfectious disease and pulmonary care companiesLife sciences startups in North Carolina
Life sciences technology and research platforms
Companies building research technology, laboratory platforms and scientific tools.
- XilisSee in list
Developer of drug discovery and precision therapy platform for oncology
Oncology - RibometrixSee in list
Provider RNA-targeted drug discovery platform
Genomics - Topography HealthSee in list
The company provides a full-stack clinical trials platform for community physicians
Life sciences tech - CodettaSee in list
Online platform for analyzing omics clinical data
Life sciences tech - Reactive BiosciencesSee in list
Developer of boron-based medicines for various disease conditions
Life sciences tech
133 companies in North CarolinaAll 79 life sciences tech companies in North Carolina →
Genomics and gene therapy companies
Companies developing genomic analysis, gene editing and related therapies.
- Atsena TherapeuticsSee in list
Developer of gene therapies for the treatment of ocular diseases
Ophthalmology - GenetronHealthSee in list
Provider of services in the development of precision medicine tools for cancer treatment
Genomics - MetabolonSee in list
Provider of solutions for biomarker discovery, diagnostic tests and personalized medicine
Metabolic diseases - PairwiseSee in list
Provider of gene editing technology for climate-resilient, nutritious, and sustainable crops
Genomics - XilisSee in list
Developer of drug discovery and precision therapy platform for oncology
Oncology
62 companies in North CarolinaAll 71 genomics companies in North Carolina →
Oncology and immunotherapy companies
Companies developing cancer therapies and immune-based treatments.
- Precision BioSciencesSee in list
Developer of gene editing therapies to treat rare genetic diseases
Gene therapy - Bryn PharmaSee in list
Developer of nasal based epinephrine for anaphylaxis
Immunotherapy - XilisSee in list
Developer of drug discovery and precision therapy platform for oncology
Oncology - Istari OncologySee in list
Developer of viral vaccines and antibody drug conjugates for the treatment of cancer
Immunotherapy - Incyclix BioSee in list
A next-generation cell cycle control company advancing precision treatments for cancer
Immunotherapy
70 companies in North CarolinaAll 49 oncology companies in North Carolina →
Medical device and orthopedic companies
Companies creating medical devices, orthopedic products and clinical equipment.
- MicellSee in list
Drug eluting coronary stent
Cardiac and vascular disorders - AeramiSee in list
Developer of therapeutics to treat cardiopulmonary diseases
Drug delivery - Contego MedicalSee in list
Provider of vascular stenting with embolic protection for both coronary and peripheral vasculature
Cardiac and vascular disorders - Pneuma RespiratorySee in list
Developer of pulmonary drug delivery solutions
Pulmonology - Precise BioSee in list
Developer of integrated 3D printing and tissue-engineering platform
3d printing
119 companies in North CarolinaAll 33 orthopedics companies in North Carolina →
Infectious disease and pulmonary care companies
Companies developing treatments for infections and respiratory conditions.
- CempraSee in list
Clinical-stage pharmaceutical company focused on developing antibacterials
Infectious diseases - AeramiSee in list
Developer of therapeutics to treat cardiopulmonary diseases
Drug delivery - NovanSee in list
Developer of Nitric Oxide based therapeutics for dermatology disorders
Dermatology - LiquidiaSee in list
Developer of therapeutics for pulmonary hypertension and cardiopulmonary conditions
Nanotechnology - Istari OncologySee in list
Developer of viral vaccines and antibody drug conjugates for the treatment of cancer
Immunotherapy
57 companies in North CarolinaAll 1,010 infectious diseases companies in United States →
Life sciences startups in North Carolina
Recently founded life sciences companies in North Carolina.
- AreteiaSee in list
Developer of therapeutics for eosinophilic asthma
Pulmonology - Slate MedicinesSee in list
Developer of therapeutics for the treatment of migraine and other headache disorders
Neurology - Tolerance BioSee in list
Developer of thymus-based therapies for immune-mediated diseases to increase healthspan
Immunology - Levee MedicalSee in list
Developer of urological devices for post-prostatectomy
Genitourinary disorders - Create WellnessSee in list
Provider of creatine monohydrate gummies to support overall well-being
Nutraceuticals tech
56 companies in North Carolina
Life sciences companies hiring in North Carolina
Life sciences companies in North Carolina with hiring activity.
- HumacyteSee in list
Provider of human tissue-based products for vascular disease
Regenerative medicine - Atsena TherapeuticsSee in list
Developer of gene therapies for the treatment of ocular diseases
Ophthalmology - MetabolonSee in list
Provider of solutions for biomarker discovery, diagnostic tests and personalized medicine
Metabolic diseases - PairwiseSee in list
Provider of gene editing technology for climate-resilient, nutritious, and sustainable crops
Genomics - XilisSee in list
Developer of drug discovery and precision therapy platform for oncology
Oncology
21 companies in North Carolina
Public life sciences companies in North Carolina
Publicly listed life sciences companies in North Carolina.
- HumacyteSee in list
Provider of human tissue-based products for vascular disease
Regenerative medicine - GenetronHealthSee in list
Provider of services in the development of precision medicine tools for cancer treatment
Genomics - Precision BioSciencesSee in list
Developer of gene editing therapies to treat rare genetic diseases
Gene therapy - NovanSee in list
Developer of Nitric Oxide based therapeutics for dermatology disorders
Dermatology - LiquidiaSee in list
Developer of therapeutics for pulmonary hypertension and cardiopulmonary conditions
Nanotechnology
19 companies in North Carolina
Mobile reach
Top 10 life sciences apps from North Carolina
The most-installed Android apps published by life sciences companies headquartered in North Carolina — 133K installs between them. 10 companies on this page publish at least one app; each company (legal entity) appears once, with its most-installed app.
1 of 10
Installs105K
Rating3.892K ratings
Installs, year on year+15%
Last updatedMay 2026
Legal entityIQVIA Holdings Inc.declared on Google Play
View on Google Play ↗
Installs15K
Rating2.07184 ratings
Last updatedMay 2026
Legal entitySleep Solutions Incdeclared on Google Play
View on Google Play ↗
Installs4K
Rating4.015 ratings
Last updatedFeb 2026
Legal entityCARDIODIAGNOSTICS TECHNOLOGIES INC.declared on Google Play
View on Google Play ↗
Installs4K
Rating2.7423 ratings
Last updatedMay 2025
Legal entityRevian, Inc.declared on Google Play
View on Google Play ↗
Installs2K
Rating—
Last updatedOct 2023
Legal entityDENTSPLY SIRONA Inc.declared on Google Play
View on Google Play ↗
Installs2K
Rating—
Last updatedJul 2025
Legal entityCEM CORPORATIONdeclared on Google Play
View on Google Play ↗
Installs404
Rating—
Last updatedApr 2026
Legal entityTruLabdeclared on Google Play
View on Google Play ↗
Installs238
Rating—
Last updatedMay 2026
Legal entityLABVOICE INC.declared on Google Play
View on Google Play ↗
Installs184
Rating—
Last updatedJun 2026
Legal entityEpividian, Inc.declared on Google Play
View on Google Play ↗
Installs36
Rating—
Last updatedApr 2026
Legal entityAMISSA, INC.declared on Google Play
View on Google Play ↗
For investors and data teams
Put this intelligence into your own tools
The figures on this page come from Fliar’s company, funding, hiring and news data. Use it through the Investor Intelligence API and company data exports, or explore every company, founder and investor in Radar.
Capital & corporate activity
Life sciences funding and M&A across the United States
22,455 recorded equity rounds have gone to 27,407 life sciences companies in the United States — how much, at which stage, into which sub-sectors, from whom, and how North Carolina compares. Debt, IPO and grant rounds are excluded.
equity rounds, last 12 months360
US$13.54bn
equity rounds, last 24 months1232
US$37.38bn
raised over five yearsUS$157.58bn
5,603 rounds in the United States
M&A deals, North Carolina29
last 24 months
Capital by year
amount roundsEquity funding into life sciences in the United States
Bars show US$ raised; the number under each year is equity rounds. 2026 is year to date. The peak year was 2021, with US$45.29bn across 1383 rounds.
The funding ladder · five years
Rounds and typical cheque by stage
AngelUS$70.78m18 rounds · median US$1.40m
SeedUS$5.87bn1,808 rounds · median US$1.11m
Series AUS$38.68bn1,753 rounds · median US$8.80m
Series BUS$46.06bn1,089 rounds · median US$23.00m
Series CUS$30.98bn517 rounds · median US$42.00m
Series D+US$35.59bn392 rounds · median US$50.00m
Private equityUS$66.54m22 rounds · median US$14.25m
Where the money went · five years
Most-funded sub-sectors
OncologyUS$24.87bn658 rounds · 368 companies
Life sciences techUS$16.70bn556 rounds · 344 companies
GenomicsUS$15.90bn409 rounds · 249 companies
NeurologyUS$13.39bn445 rounds · 248 companies
ImmunologyUS$12.90bn189 rounds · 111 companies
Life sciences platforms and toolsUS$7.97bn387 rounds · 238 companies
Cardiac and vascular disordersUS$7.63bn313 rounds · 172 companies
North Carolina in context
North Carolina’s share of the United States’s life sciences funding
Equity rounds over the last five years, 700 life sciences companies in North Carolina among 27,407 in the United States.
Corporate activity · last 24 months
M&A in North Carolina
27Acquisition
2Merger
Most active acquirers
- Biocryst pharmaceuticals3
- Stiefel Laboratories2
- Foundation medicine1
- Neopharmed gentili1
- Mars1
Most acquired or merged
- Biocryst pharmaceuticals6
- Astria therapeutics3
- TriPath Imaging3
- Etrials worldwide2
- Saga diagnostics1
Each deal appears in the events strip at the top of the page.
Go deeper in the life sciences landscape reports:
Life Sciences Industry Landscape of the United StatesIndustry landscape report
Life Sciences Industry Landscape of the United States
The financials above are one chapter. The full life sciences landscape of North Carolina maps the whole industry — every segment, the capital behind it, the talent market and where the next opportunities are.
- Market map of every sub-sector
- Funding & company formation by year
- Revenue, profit & financial strength
- Digital footprint: traffic, apps, releases
- Hiring, skills & pay
- Founders & leaders
- News & sentiment
- Where demand runs ahead of supply
Life sciences funding in North Carolina
148 life sciences companies in North Carolina have recorded equity funding, US$4.81bn in total. Totals and round dates describe the historical record; they are not current valuations.
Most funded
Largest recorded equity totals, with the latest recorded round.
PulmonologyDeveloper of therapeutics for eosinophilic asthma
Recorded equity fundingUS$435.00mSeries A · Feb 2024
Leadership · 1
Regenerative medicineProvider of human tissue-based products for vascular disease
Recorded equity fundingUS$424.76mSeries D · Jun 2018
Founder · 1
Juliana Blum in ↗Co-Founder, Executive Advisor
OphthalmologyDeveloper of gene therapies for the treatment of ocular diseases
Recorded equity fundingUS$238.00mSeries C · Mar 2025
Founder · 1
Shannon Boye in ↗Founder & Director
GenomicsProvider of services in the development of precision medicine tools for cancer treatment
Recorded equity fundingUS$191.06mSeries D · Nov 2019
Founder · 1
Sizhen Wang in ↗Co-Founder & CEO
Metabolic diseasesProvider of solutions for biomarker discovery, diagnostic tests and personalized medicine
Recorded equity fundingUS$165.87mSeries H · Dec 2024
Founder · 1
John Ryals in ↗Ex-Founder
Cardiac and vascular disordersDrug eluting coronary stent
Recorded equity fundingUS$157.52mSeries D · Sep 2017
Leadership · 1
Arthur BenvenutoChairman & CEO
GenomicsProvider of gene editing technology for climate-resilient, nutritious, and sustainable crops
Recorded equity fundingUS$155.00mSeries C · Sep 2024
Leadership · 1
Infectious diseasesClinical-stage pharmaceutical company focused on developing antibacterials
Recorded equity fundingUS$149.50mSeries C · May 2010
Founders
Details not available
Gene therapyDeveloper of gene editing therapies to treat rare genetic diseases
Recorded equity fundingUS$135.65mSeries B · Jun 2018
Leadership · 1
NeurologyDeveloper of therapeutics for the treatment of migraine and other headache disorders
Recorded equity fundingUS$130.00mSeries A · Feb 2026
Founder · 1
Neil Buckley in ↗Co-Founder & CEO
ImmunotherapyDeveloper of nasal based epinephrine for anaphylaxis
Recorded equity fundingUS$127.68mSeries C · Apr 2025
Leadership · 1
David Dworaczyk in ↗Retired CEO: Corporate Advisor/Consultant to Bryn Pharma, LLC
Drug deliveryDeveloper of therapeutics to treat cardiopulmonary diseases
Recorded equity fundingUS$126.60mSeries B · Nov 2023
Founder · 1
John Patton in ↗Founder
Drug deliveryTargeted drug delivery platforms optimizing neurological disorder treatment and patient outcomes
Recorded equity fundingUS$119.30mSeries B · Jan 2021
Leadership · 1
Steve AdlerCEO
OncologyDeveloper of drug discovery and precision therapy platform for oncology
Recorded equity fundingUS$116.26mSeries B · Apr 2025
Founder · 1
Hans CleversCo-Founder
DermatologyDeveloper of Nitric Oxide based therapeutics for dermatology disorders
Recorded equity fundingUS$112.84mSeries C · Dec 2015
Leadership · 1
Paula Brown Stafford in ↗CEO & President
DermatologyProvider of healthcare solutions
Recorded equity fundingUS$106.25mSeries E · Apr 2020
Leadership · 1
Steve Woody in ↗CEO & Director
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 19
- Recorded funding
- US$435.00m · Series A · Feb 2024
- Founded
- 2022 · about 4 years old
- Stage
- Series A
- Focus
- Drugs, Copd and asthma, Asthma
Funding over time
US$435.00m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Jorge BartolomeCEO
- Highest education
- Duke University
Investors · 10
- Google VenturesFund
- Marshall WaceFund
- Maverick CapitalFund
- SanofiFund
Team & hiring signals
LinkedIn headcount1011-50
LinkedIn followers2,338
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 70
- Recorded funding
- US$424.76m · Series D · Jun 2018
- Founded
- 2004 · about 22 years old
- Stage
- Public
- Focus
- Diversified, Drugs
Funding over time
US$424.76m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Juliana BlumCo-Founder, Executive Advisor
Investors · 7
- Bangkok BankFund
- Pacific EagleFund
- Reignwood GroupFund
- Brady DouganAngel
Team & hiring signals
LinkedIn headcount159201-500
LinkedIn followers16,756
Earlier recorded team702022, a different source
Open roles1of 3 tracked · last posted Mar 2026
LinkedIn page Patents
Patent filings137
Focus: Engineered vascular grafts and medicated implantable matrices for blood vessel replacement.
CPC C12N5/0068, A61F2/20, A61L27/3633Technology
- AWS
- PHP
- MySQL
- Nginx
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 23 (previous snapshot 49)
- Recorded funding
- US$238.00m · Series C · Mar 2025
- Founded
- 2020 · about 6 years old
- Stage
- Series C
- Focus
- Drugs, Retinal disorders
Funding over time
US$238.00m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Shannon BoyeFounder & Director
- Highest education
- Doctorates in neuroscience · University Of Florida
Investors · 11
- AbingworthFund
Team & hiring signals
LinkedIn headcount4911-50
LinkedIn followers13,782
Earlier recorded team232022, a different source
Open roles1of 8 tracked · last posted Jun 2026
LinkedIn page Recent company signals
- Milestone first patient in Phase 3 pivotal cohort of the LIGHTHOUSE trial evaluating ATSN-201 for X-linked retinoschisis (#XLRS) patient doses
Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 993
- Recorded funding
- US$191.06m · Series D · Nov 2019
- Founded
- 2013 · about 13 years old
- Stage
- Public
- Focus
- Applied genomics, Clinical genomics, Diagnostics, Sequencing-based
Funding over time
US$191.06m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Sizhen WangCo-Founder & CEO
- Highest education
- Master's of business administration in finance · Ecole Des Hautes Etudes Commerciales
Investors · 11
- AlexandriaFund
- CICCFund
- Share CapitalFund
- V Star CapitalFund
Team & hiring signals
LinkedIn headcount96501-1,000
LinkedIn followers1,189
Earlier recorded team9932022, a different source
LinkedIn page Technology
- Nginx
- Bootstrap
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SoftwareHas made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 189 (previous snapshot 311)
- Recorded funding
- US$165.87m · Series H · Dec 2024
- Founded
- 2000 · about 26 years old
- Stage
- Series H
- Focus
- In vitro diagnostic tests, Inborn errors of metabolism, Genomics research, Biomarker discovery
Funding over time
US$165.87m across 15 disclosed equity rounds
Darker bars = larger roundsFounders · 1
John RyalsEx-Founder
Investors · 12
- AlexandriaFund
- Camden PartnersFund
- Fletcher SpaghtFund
- Sevin RosenFund
- The Aurora FundsFund
Team & hiring signals
LinkedIn headcount203201-500
LinkedIn followers22,872
Earlier recorded team1892022, a different source
Open roles4of 8 tracked · last posted Apr 2026
LinkedIn page Patents
Patent filings400
Focus: Metabolomics biomarker discovery and diagnostic assays for metabolic and inflammatory diseases
CPC G01N33/6893, G01N33/92, G01N33/6848Technology
- PHP
- MySQL
- Cloudflare
- HubSpot
- Salesforce
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 2 (previous snapshot 13)
- Recorded funding
- US$157.52m · Series D · Sep 2017
- Founded
- 1995 · about 31 years old
- Stage
- Series D
- Focus
- Medical devices, Therapeutic devices, Coronary and peripheral vascular diseases, Coronary artery diseases
Funding over time
US$157.52m across 11 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Arthur BenvenutoChairman & CEO
Investors · 3
- St. Jude MedicalFund
Team & hiring signals
LinkedIn headcount911-50
LinkedIn followers493
Earlier recorded team22020, a different source
LinkedIn page Patents
Patent filings363
Focus: Bioabsorbable polymer drug‑eluting coatings for stents and medical devices
CPC A61L31/16, A61F2/82, A61L31/10Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 163 (previous snapshot 158)
- Recorded funding
- US$155.00m · Series C · Sep 2024
- Founded
- 2017 · about 9 years old
- Stage
- Series C
- Focus
- Applied genomics, Agrigenomics, Farm inputs, Seeds
Funding over time
US$155.00m across 3 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Tom AdamsCEO
Investors · 6
- Aliment CapitalFund
- DeerfieldFund
- Leaps by BayerFund
- MonsantoFund
- TemasekFund
Team & hiring signals
LinkedIn headcount11551-200
LinkedIn followers18,199
Open roles1of 1 tracked · last posted Jun 2026
- Internship: 2026 Summer Intern
Recent company signals
- Partnership Partnership with Pipewise
Technology
- Cloudflare
- HubSpot
- Webflow
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 78 (previous snapshot 16)
- Recorded funding
- US$149.50m · Series C · May 2010
- Founded
- 2006 · about 20 years old
- Stage
- Series C
- Focus
- Drugs, Bacterial, Drug resistant infections
Funding over time
US$149.50m across 5 disclosed equity rounds
Darker bars = larger roundsInvestors · 6
- Aisling CapitalFund
- Devon Park BioVenturesFund
- Quaker PartnersFund
Team & hiring signals
LinkedIn headcount1151-200
LinkedIn followers2,054
Earlier recorded team782015, a different source
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 236
- Recorded funding
- US$135.65m · Series B · Jun 2018
- Founded
- 2006 · about 20 years old
- Stage
- Public
- Focus
- Enabling technologies, Technology platforms, Gene editing, Drugs
Funding over time
US$135.65m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Matthew KaneCEO
Investors · 20
- Agent CapitalFund
- Aliment CapitalFund
- BaxterFund
- CowenFund
Team & hiring signals
LinkedIn headcount10051-200
LinkedIn followers24,648
Earlier recorded team2362022, a different source
Open roles1of 1 tracked · last posted Mar 2026
LinkedIn page Patents
Patent filings68
Focus: Precise gene editing tools for therapeutic targets and engineered cell therapies
CPC C12N9/22, A61K38/465, C07K14/7151Technology
- AWS
- PHP
- MySQL
- Nginx
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- Not available
- Recorded funding
- US$130.00m · Series A · Feb 2026
- Founded
- 2026 · about 0 years old
- Stage
- Series A
- Focus
- Drugs, Pain
Founders · 1
Neil BuckleyCo-Founder & CEO
- Highest education
- MS · Northeastern University
Investors · 3
- ForbionFund
- Foresite CapitalFund
Team & hiring signals
LinkedIn headcount72-10
LinkedIn followers1,001
LinkedIn page Recent company signals
- Leadership Hired a Chief Financial Officer
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 10 (previous snapshot 11)
- Recorded funding
- US$127.68m · Series C · Apr 2025
- Founded
- 2018 · about 8 years old
- Stage
- Series C
- Focus
- Drugs, Allergies, Anaphylactic shock
Funding over time
US$127.68m across 6 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
David DworaczykRetired CEO: Corporate Advisor/Consultant to Bryn Pharma, LLC
- Highest education
- Doctorates, Leadership · University Of Delaware
Team & hiring signals
LinkedIn headcount42-10
LinkedIn followers2,269
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 17 (previous snapshot 18)
- Recorded funding
- US$126.60m · Series B · Nov 2023
- Founded
- 2010 · about 16 years old
- Stage
- Series B
- Focus
- Medical devices, Therapeutic devices, Drug delivery, Inhaled
Funding over time
US$126.60m across 12 disclosed equity rounds
Darker bars = larger roundsFounders · 1
John PattonFounder
Investors · 2
- MolexFund
- Molex VenturesFund
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SoftwareHardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 72
- Recorded funding
- US$119.30m · Series B · Jan 2021
- Founded
- 2005 · about 21 years old
- Stage
- Series B
- Focus
- Implants
Funding over time
US$119.30m across 8 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Steve AdlerCEO
Investors · 4
- BlackstoneFund
- Elevage CapitalFund
- Hercules CapitalFund
Team & hiring signals
LinkedIn headcount1651-200
LinkedIn followers6,224
Earlier recorded team722020, a different source
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 72
- Recorded funding
- US$116.26m · Series B · Apr 2025
- Founded
- 2019 · about 7 years old
- Stage
- Series B
- Focus
- Research assays, Drug discovery, Organoid models, Patient derived cancer cell models
Funding over time
US$116.26m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Hans CleversCo-Founder
Investors · 14
- AlexandriaFund
- Alix VenturesFund
- Duke UniversityFund
- EQTFund
- FPV VenturesFund
- Felicis VenturesFund
Team & hiring signals
LinkedIn headcount1051-200
LinkedIn followers7,314
Open roles0of 2 tracked · last posted Jul 2025
LinkedIn page Patents
Patent filings97
Focus: Microfluidic organoid droplet generation and component delivery for personalized medicine
CPC B01L3/502784, C12N5/0693, G01N33/5011Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Has made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 89 (previous snapshot 60)
- Recorded funding
- US$112.84m · Series C · Dec 2015
- Founded
- 2006 · about 20 years old
- Stage
- Public
- Focus
- Drugs, Viral, Hpv, Diversified
Funding over time
US$112.84m across 6 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Paula Brown StaffordCEO & President
- Highest education
- Bachelor's in public health · University Of North Carolina At Chapel Hill
Investors · 2
- Malin PLCFund
- John PalmourAngel
Team & hiring signals
LinkedIn headcount10551-200
LinkedIn followers4,292
Earlier recorded team892022, a different source
LinkedIn page Recent company signals
- Milestone member of Russell 3000ETM Growth Benchmark, Russell Microcap®, and Russell Microcap® Growth Benchmark Indexes growth Benchmark, Russell Micr
Patents
Patent filings227
Focus: Topical pharmaceutical formulations for nitric‑oxide, antiviral, and wound‑healing applications
CPC A61K9/0014, A61K33/00, A61K31/695Technology
- PHP
- MySQL
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Consumer
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product
- Team size
- 94 (previous snapshot 74)
- Recorded funding
- US$106.25m · Series E · Apr 2020
- Founded
- 2007 · about 19 years old
- Stage
- Series E
- Focus
- Drugs, Muscle disorders, Diversified
Funding over time
US$106.25m across 45 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Steve WoodyCEO & Director
- Highest education
- Bachelor's Of Science · UNC Asheville
Team & hiring signals
LinkedIn headcount7651-200
LinkedIn followers1,921
Open roles1of 2 tracked · last posted Dec 2025
- Hiring: Accounts Receivable / Accounts Payable Manager · Charlotte, North Carolina
- Hiring: Arcs Receivable / Accounts Payable Manager · Swannanoa or Charlotte, NC area
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Founders and momentum in North Carolina
Meet the people behind life sciences companies in North Carolina. 304 of 461 companies list founders or leaders; where a public LinkedIn profile matches exactly, the expanded profile shows the photo, headline, location and education.
Growing teams
Companies whose recorded headcount rose the most between the two most recent team-size snapshots. A larger team is a signal of momentum, not of profitability.
Life sciences techProvider of clinical research and commercialization solutions for healthcare
Team size87,000Up from 586 in the previous snapshot
Founders · 2
Luciano CatoniFounder, Chairman of the Board of Directors
Dennis GillingsFounder
Infectious diseasesClinical-stage pharmaceutical company focused on developing antibacterials
Team size78Up from 16 in the previous snapshot
Founders
Details not available
Life sciences techDeveloper of analytical software for workflow automation
Team size18Up from 11 in the previous snapshot
Leadership · 1
Joseph Simpkins in ↗Owner & CEO
Dental disordersDeveloper of dental products and equipment
Team size15,000Up from 9,206 in the previous snapshot
Founders
Details not available
Cad treatment devicesTryton Medical manufactures and sells stent systems for the treatment of bifurcation lesions.
Team size25Up from 16 in the previous snapshot
Founders
Details not available
NephrologyDeveloper of therapeutics for the treatment of chronic kidney disease
Team size122Up from 79 in the previous snapshot
Leadership · 1
Healthtech saasEpividian provides novel research services for clinical practice, clinical research, academic, public health, and regulatory purposes.
Team size18Up from 12 in the previous snapshot
Founders
Details not available
DermatologyDeveloper of Nitric Oxide based therapeutics for dermatology disorders
Team size89Up from 60 in the previous snapshot
Leadership · 1
Paula Brown Stafford in ↗CEO & President
Infectious diseasesDeveloper of small molecule based therapeutics for the treatment of recurrent vulvovaginal candidiasis
Team size61Up from 42 in the previous snapshot
Founders
Details not available
GenomicsDeveloper of a predictive breeding platform to identify crop traits and build crop models
Team size24Up from 17 in the previous snapshot
Founders · 2
Spencer Maughan in ↗Co-Founder & Chairman
Philip Benfey in ↗Co-Founder & Chairman
GastroenterologyDeveloper of drug compounds to treat short bowel syndrome and celiac disease
Team size21Up from 15 in the previous snapshot
Leadership · 1
John Temperato in ↗CEO & President
Cardiac and vascular disordersProvider of vascular stenting with embolic protection for both coronary and peripheral vasculature
Team size33Up from 24 in the previous snapshot
Founder · 1
Ravish Sachar in ↗Founder & CEO
SaaSSoftwareHas made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 87,000 (previous snapshot 586)
- Recorded funding
- None recorded
- Founded
- 1982 · about 44 years old
- Stage
- Public
- Focus
- Research & development, Clinical trials, Patient interaction, Industry specific marketing
Founders · 2
Luciano CatoniFounder, Chairman of the Board of Directors
Dennis GillingsFounder
Investors · 1
3i GroupFund
Team & hiring signals
LinkedIn headcount85,80510,001+
LinkedIn followers2,728,991
Earlier recorded team87,0002023, a different source
LinkedIn page Recent company signals
- Partnership Partnership with Gaates Medical Research Institute
Patents
Patent filings219
Focus: Health data analytics and AI-driven clinical trial design, monitoring, and regulatory intelligence.
CPC G16H10/20, G16H10/60, G16H40/20Mobile apps
- IQVIA Study HubHealth & Fitness · 105,417 installs · ★ 3.9 · updated 2026-05-23
- Sales ViewBusiness · 94,435 installs · updated 2022-09-01
- OCEMedical · 11,180 installs · updated 2026-05-20
Technology
- AWS
- Azure
- React
Next.js
Angular
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 78 (previous snapshot 16)
- Recorded funding
- US$149.50m · Series C · May 2010
- Founded
- 2006 · about 20 years old
- Stage
- Series C
- Focus
- Drugs, Bacterial, Drug resistant infections
Funding over time
US$149.50m across 5 disclosed equity rounds
Darker bars = larger roundsInvestors · 6
- Aisling CapitalFund
- Devon Park BioVenturesFund
- Quaker PartnersFund
Team & hiring signals
LinkedIn headcount1151-200
LinkedIn followers2,054
Earlier recorded team782015, a different source
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 18 (previous snapshot 11)
- Recorded funding
- None recorded
- Founded
- 2008 · about 18 years old
- Stage
- Unfunded
- Focus
- Research & development, Laboratory management, Laboratory automation, Pathology
Leadership · 1
Joseph SimpkinsOwner & CEO
- Highest education
- Master's of science in aerospace engineering in mathematics · North Carolina State University
Team & hiring signals
LinkedIn headcount2011-50
LinkedIn followers1,136
LinkedIn page Recent company signals
- Partnership Partnership with Agilent Technologies
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
HardwareAcquirer · 1 deal
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 15,000 (previous snapshot 9,206)
- Recorded funding
- None recorded
- Founded
- 1899 · about 127 years old
- Stage
- Public
- Focus
- Medical devices, Therapeutic devices, Diversified
Investors · 1
- Kelso & CompanyFund
Team & hiring signals
LinkedIn headcount11,32610,001+
LinkedIn followers411,626
Earlier recorded team15,0002023, a different source
Open roles6of 51 tracked · last posted Jun 2026
LinkedIn page Patents
Patent filings2364
Focus: Dental imaging, handpieces, impression materials, bone regeneration, and 3D‑printed dental models
CPC A61C13/0004, A61C13/0022, A61C5/50Mobile apps
- DS Core LinkBusiness · 4,148 installs · updated 2026-05-22
- Dentsply Sirona SMA 2.0Business · 2,135 installs · updated 2023-10-13
Technology
- AWS
- React
- Next.js
- Angular
Node.js
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 25 (previous snapshot 16)
- Recorded funding
- None recorded
- Founded
- 2003 · about 23 years old
- Stage
- Private
- Focus
- Coronary artery diseases, Coronary and peripheral vascular diseases, Implants, Medical devices
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Has made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 122 (previous snapshot 79)
- Recorded funding
- None recorded
- Founded
- 2018 · about 8 years old
- Stage
- Public
- Focus
- Drugs, Renal disorders
Leadership · 1
Tim BertramCEO
- Highest education
- Iowa State University
Team & hiring signals
LinkedIn headcount23951-200
LinkedIn followers11,198
Open roles4of 12 tracked · last posted May 2026
LinkedIn page Technology
- AWS
- PHP
- MySQL
- Nginx
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 18 (previous snapshot 12)
- Recorded funding
- None recorded
- Founded
- 2012 · about 14 years old
- Stage
- Private
- Focus
- Ctms and edc, Clinical data management, Clinical trials, Data discovery and visualization
Team & hiring signals
LinkedIn headcount2611-50
LinkedIn followers521
LinkedIn page Mobile apps
- Epividian CHORUSHealth & Fitness · 184 installs · updated 2026-06-04
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Has made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 89 (previous snapshot 60)
- Recorded funding
- US$112.84m · Series C · Dec 2015
- Founded
- 2006 · about 20 years old
- Stage
- Public
- Focus
- Drugs, Viral, Hpv, Diversified
Funding over time
US$112.84m across 6 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Paula Brown StaffordCEO & President
- Highest education
- Bachelor's in public health · University Of North Carolina At Chapel Hill
Investors · 2
- Malin PLCFund
- John PalmourAngel
Team & hiring signals
LinkedIn headcount10551-200
LinkedIn followers4,292
Earlier recorded team892022, a different source
LinkedIn page Recent company signals
- Milestone member of Russell 3000ETM Growth Benchmark, Russell Microcap®, and Russell Microcap® Growth Benchmark Indexes growth Benchmark, Russell Micr
Patents
Patent filings227
Focus: Topical pharmaceutical formulations for nitric‑oxide, antiviral, and wound‑healing applications
CPC A61K9/0014, A61K33/00, A61K31/695Technology
- PHP
- MySQL
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 61 (previous snapshot 42)
- Recorded funding
- None recorded
- Founded
- 2018 · about 8 years old
- Stage
- Funding Raised
- Focus
- Drugs, Fungal
Team & hiring signals
LinkedIn headcount102-10
LinkedIn followers3,587
LinkedIn page Technology
- PHP
- MySQL
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce, Subscription
- Team size
- 24 (previous snapshot 17)
- Recorded funding
- US$8.50m · Series A · Dec 2018
- Founded
- 2014 · about 12 years old
- Stage
- Series A
- Focus
- Farm inputs, Plant breeding, Management solutions, Analytics
Founders · 2
Spencer MaughanCo-Founder & Chairman
Philip BenfeyCo-Founder & Chairman
- Highest education
- Doctorates in biology · Harvard University
Investors · 7
GRO AllianceFund
KdT VenturesFund
S2G VenturesFund
Tom FarmsFund
Team & hiring signals
LinkedIn headcount52-10
LinkedIn followers516
Earlier recorded team242021, a different source
LinkedIn page Patents
Patent filings37
Focus: Non‑invasive root phenotyping for agricultural plant imaging and phenomics
CPC G01N33/0098, C12Q1/6895, G01N21/84Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 21 (previous snapshot 15)
- Recorded funding
- None recorded
- Founded
- 2012 · about 14 years old
- Stage
- Public
- Focus
- Drugs, Bowel disorders, Short bowel syndrome
Leadership · 1
John TemperatoCEO & President
Patents
Patent filings43
Focus: Therapeutics targeting intestinal tight junctions and barrier permeability for GI disorders.
CPC A61K38/08, A61K45/06, A61K31/655Technology
- AWS
- PHP
- MySQL
- Cloudflare
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 33 (previous snapshot 24)
- Recorded funding
- US$66.01m · Series D · Apr 2023
- Founded
- 2005 · about 21 years old
- Stage
- Series D
- Focus
- Medical devices, Therapeutic devices, Coronary and peripheral vascular diseases, Diversified
Funding over time
US$66.01m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Ravish SacharFounder & CEO
- Highest education
- Doctor of Medicine · Columbia University
Investors · 9
- Lookout CapitalFund
- MedtronicFund
- NCBiotechFund
Team & hiring signals
LinkedIn headcount5011-50
LinkedIn followers3,071
LinkedIn page Technology
- PHP
- MySQL
- Cloudflare
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Women-founded
Life sciences companies in North Carolina with at least one woman on the founding team. Expand a profile to meet the founders; teams can include both women and men.
GenomicsDeveloper of AAV based gene therapies for rare diseases
Revenue modelSubscription
Founders · 3
Aravind Asokan in ↗Co-Founder
Mavis Agbandje-McKennaCo-Founder & Director
Patrick Ritschel in ↗Co-Founder
Regenerative medicineProvider of human tissue-based products for vascular disease
Revenue modelPhysical commerce
Founder · 1
Juliana Blum in ↗Co-Founder, Executive Advisor
Life sciences platforms and toolsProvider of invitro platform for drug testing
Revenue modelPhysical commerce
Founders · 5
Scott Magness in ↗Co-Founder
Nancy Allbritton in ↗Co-Founder
Michael Biron in ↗Co-Founder & CEO
Yuli WangCo-Founder & CSO
Christopher Sims Md in ↗Founder, Principle Investigator and Board Member
GenomicsProvider RNA-targeted drug discovery platform
Revenue modelSubscription
Founder · 1
Katie Warner in ↗Co-Founder
Disease self managementProvider of sleep management systems
Revenue modelSubscription
Founders · 2
Tara Youngblood in ↗Co-Founder & VP
Todd Youngblood in ↗Co-Founder
Life sciences techCloud based platform to match patients with clinical trials.
Revenue modelSubscription
Founder · 1
Courtney Hudson in ↗Founder & CEO
Nutraceuticals techProvider of creatine monohydrate gummies to support overall well-being
Revenue modelE-commerce - product
Founders · 2
Sienna McCormick in ↗Co-Founder & Co-CEO
Daniel McCormick in ↗Co-Founder & CEO
Regenerative medicineProvider of animal-free collagen and gelatin products for multiple industries
Revenue modelE-commerce - product / Physical commerce
Founder · 1
Stephanie Michelsen in ↗Co-Founder & CEO
DermatologyDiagnostic company that develops non-invasive biomarker tests to measure cellular aging and predict the risk of age-related diseases
Revenue modelFee-for-service
Founders · 2
Norman SharplessCo-Founder
Natalia Mitin in ↗Co-Founder & CEO
Life sciences techDeveloper of formulation technology for bio-therapeutics drug delivery
Revenue modelPhysical commerce
Founder · 1
Karen LeVert in ↗Co-Founder & CEO
OphthalmologyDeveloper of therapies for treating infection, inflammation, and pain
Revenue modelE-commerce - product / Physical commerce
Founder · 1
Laurene WangFounder & CEO
OrthopedicsProvider of therapeutics for orthopedic indications
Revenue modelE-commerce - product / Physical commerce
Founders · 2
Alessandra Pavesio in ↗Co-Founder & CEO
Sarah Caley in ↗Co-Founder
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 109 (previous snapshot 120)
- Recorded funding
- US$98.20m · Series B · Mar 2021
- Founded
- 2015 · about 11 years old
- Stage
- Series B
- Focus
- Drugs, Diversified, Enabling technologies, Technology platforms
Funding over time
US$98.20m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 3
Aravind AsokanCo-Founder
- Highest education
- Virology · University Of North Carolina At Chapel Hill School Of Medicine
Mavis Agbandje-McKennaCo-Founder & Director
Patrick RitschelCo-Founder
- Highest education
- Bachelor's in mechanical engineering · University Of Illinois At Urbana - Champaign
Investors · 12
- AlexandriaFund
- Novo HoldingsFund
- PontifaxFund
- SareptaFund
Team & hiring signals
LinkedIn headcount451-200
LinkedIn followers5,067
Earlier recorded team1092022, a different source
LinkedIn page Patents
Patent filings89
Focus: Recombinant AAV vector design, manufacturing, and gene‑therapy delivery platforms
CPC C12N15/86, C07K14/005, C07K14/47Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 70
- Recorded funding
- US$424.76m · Series D · Jun 2018
- Founded
- 2004 · about 22 years old
- Stage
- Public
- Focus
- Diversified, Drugs
Funding over time
US$424.76m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Juliana BlumCo-Founder, Executive Advisor
Investors · 7
- Bangkok BankFund
- Pacific EagleFund
- Reignwood GroupFund
- Brady DouganAngel
Team & hiring signals
LinkedIn headcount159201-500
LinkedIn followers16,756
Earlier recorded team702022, a different source
Open roles1of 3 tracked · last posted Mar 2026
LinkedIn page Patents
Patent filings137
Focus: Engineered vascular grafts and medicated implantable matrices for blood vessel replacement.
CPC C12N5/0068, A61F2/20, A61L27/3633Technology
- AWS
- PHP
- MySQL
- Nginx
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 29 (previous snapshot 26)
- Recorded funding
- US$7.53m · Seed · Mar 2025
- Founded
- 2015 · about 11 years old
- Stage
- Seed
- Focus
- Research assays, Cell based assays, Toxicity assays
Funding over time
US$7.53m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 5
Scott MagnessCo-Founder
- Highest education
- BS · University of California San Diego
Nancy AllbrittonCo-Founder
- Highest education
- BS · Louisiana State University
Michael BironCo-Founder & CEO
- Highest education
- MBA · UNC Kenan-Flagler Business School
Yuli WangCo-Founder & CSO
Christopher Sims MdFounder, Principle Investigator and Board Member
- Highest education
- Biology · Uc Irvine
Investors · 5
RTP CapitalFund
VentureSouthFund
Team & hiring signals
LinkedIn headcount2911-50
LinkedIn followers7,485
LinkedIn page Technology
- Cloudflare
- HubSpot
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 26 (previous snapshot 34)
- Recorded funding
- US$65.30m · Series A · Sep 2019
- Founded
- 2016 · about 10 years old
- Stage
- Series A
- Focus
- Applied genomics, Clinical genomics, Therapeutics, Research assays
Funding over time
US$65.30m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Katie WarnerCo-Founder
Investors · 12
- AbbVieFund
- AlexandriaFund
- M VenturesFund
- Pappas CapitalFund
Team & hiring signals
LinkedIn headcount2111-50
LinkedIn followers3,907
Earlier recorded team262022, a different source
LinkedIn page Patents
Patent filings9
Focus: eIF4E inhibitor small molecules for oncology therapeutics
CPC C07D239/90, C07D471/04, A61P35/00Technology
- AWS
- PHP
- MySQL
- Nginx
- Cloudflare
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
ConsumerSoftwareHardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 21 (previous snapshot 54)
- Recorded funding
- US$37.00m · Series C · Dec 2020
- Founded
- 2007 · about 19 years old
- Stage
- Series C
- Focus
- Sleep, Monitoring, Quality of sleep, Device
Founders · 2
Tara YoungbloodCo-Founder & VP
- Highest education
- Mathematics · Principia College
Todd YoungbloodCo-Founder
- Highest education
- Bachelor's of Arts · Principia College
Investors · 1
- KKRFund
Team & hiring signals
LinkedIn headcount2311-50
LinkedIn followers1,722
Earlier recorded team212023, a different source
LinkedIn page Recent company signals
- Expansion transitioned manufacturing and assembly operations from overseas to new facility in Mooresville, NC
Patents
Patent filings31
Focus: Smart therapeutic bedding systems for stress reduction, sleep enhancement, and weight‑loss support
CPC A47C21/04, A61M21/02, A61B5/4815Mobile apps
- ChilipadHealth & Fitness · 15,322 installs · ★ 2.1 · updated 2026-05-25
Technology
- AWS
- Vue.js
- Cloudflare
- Segment
- Zendesk
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
ConsumerSaaSSocial impactSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 13 (previous snapshot 18)
- Recorded funding
- US$3.00m · Series B · Jan 2006
- Founded
- 2000 · about 26 years old
- Stage
- Series B
- Focus
- Research & development, Clinical trials, Scientific sourcing, Patients
Founders · 1
Courtney HudsonFounder & CEO
- Highest education
- Yale University
Investors · 4
Rand CapitalFund
Spring BayFund
Technology
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Consumer
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product
- Team size
- 8
- Recorded funding
- US$27.33m · Series B · Mar 2026
- Founded
- 2022 · about 4 years old
- Stage
- Series B
- Focus
- Supplements, Multicategory, Gummies
Funding over time
US$27.33m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Sienna McCormickCo-Founder & Co-CEO
- Highest education
- Bachelor's of Arts - BA, Economics, Finance, and Chinese · Georgetown University
Daniel McCormickCo-Founder & CEO
- Highest education
- Georgetown University
Investors · 3
- ACGFund
- Impact CapitalFund
Team & hiring signals
LinkedIn headcount5711-50
LinkedIn followers10,170
Open roles5of 11 tracked · last posted Apr 2026
LinkedIn page Recent company signals
- Launch Launched Single Serve daily pouches (three gummies, one pouch) (creatine + Electrolytes sticks)
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 7 (previous snapshot 10)
- Recorded funding
- US$5.50m · Seed · Aug 2023
- Founded
- 2020 · about 6 years old
- Stage
- Seed
- Focus
- Novel foods, Food ingredients, Protein, Lab grown
Funding over time
US$5.50m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Stephanie MichelsenCo-Founder & CEO
- Highest education
- Master's of Science · University of Copenhagen
Investors · 12
ByfoundersFund
SFVFund
Siddhi CapitalFund
Team & hiring signals
LinkedIn headcount92-10
LinkedIn followers4,801
Earlier recorded team72022, a different source
Open roles0of 2 tracked · last posted Jan 2025
LinkedIn page Recent company signals
- Award Sustainable Tech Innovation — NC TECH Awards
Patents
Patent filings10
Focus: Cultured-cell derived collagen/gelatin production for biomaterials and tissue engineering
CPC C07K14/78, G01N33/5038Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 5 (previous snapshot 12)
- Recorded funding
- US$500k · Seed · Jun 2024
- Founded
- 2013 · about 13 years old
- Stage
- Seed
- Focus
- In vitro diagnostics tests, In-vitro diagnostic tests, Diversified, In-vitro diagnostics
Founders · 2
Norman SharplessCo-Founder
Natalia MitinCo-Founder & CEO
- Highest education
- Doctor of Philosophy · Bowling Green State University
Team & hiring signals
LinkedIn headcount62-10
LinkedIn followers392
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 4
- Recorded funding
- US$7.26m · Series B · Mar 2024
- Founded
- 2016 · about 10 years old
- Stage
- Series B
- Focus
- Research & development, Drug formulation
Funding over time
US$7.26m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Karen LeVertCo-Founder & CEO
- Highest education
- BS · Eastern Michigan University
Investors · 2
Team & hiring signals
LinkedIn headcount2411-50
LinkedIn followers1,456
Earlier recorded team42019, a different source
LinkedIn page Technology
Google Cloud- React
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 3
- Recorded funding
- US$200k · Seed · Apr 2017
- Founded
- 2017 · about 9 years old
- Stage
- Seed
- Focus
- Drugs, Diversified
Founders · 1
Laurene WangFounder & CEO
Team & hiring signals
LinkedIn headcount42-10
LinkedIn followers423
Earlier recorded team32022, a different source
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- Not available
- Recorded funding
- US$11.00m · Series A · Nov 2024
- Founded
- 2023 · about 3 years old
- Stage
- Series A
- Focus
- Drugs, Osteoarthritis
Founders · 2
Alessandra PavesioCo-Founder & CEO
- Highest education
- Chemistry · University Of Torino
Sarah CaleyCo-Founder
- Highest education
- Doctorates in microbiology · University Of North Carolina At Chapel Hill School Of Medicine
Investors · 1
Team & hiring signals
LinkedIn headcount82-10
LinkedIn followers726
Open roles1of 1 tracked · last posted Jan 2026
- Hiring: Clinical Operations professional · Cathleen Hill, NC
Recent company signals
- Milestone dosed first patient in Phase 3 study of MOTYS (PTP-001) first patient dosed in Phase 3 study of MOTYS (PTP-001) for the treatment of knee os
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Recently founded
Life sciences companies in North Carolina founded in the last four years, newest first.
NeurologyDeveloper of therapeutics for the treatment of migraine and other headache disorders
Founded2026Series A
Founder · 1
Neil Buckley in ↗Co-Founder & CEO
Life sciences platforms and toolsProvider of advanced molecular testing and analysis services for research.
Founded2025Seed
Founders
Details not available
Life sciences platforms and toolsDeveloper of a platform for AI-guided cell manufacturing and development
Founded2024Seed
Founders
Details not available
OphthalmologyDeveloper of refractive vision correction implant designed to address myopia and hyperopia
Founded2024Unfunded
Founders · 2
Steven Bacich in ↗Co-Founder
Timothy WillisCo-Founder
Nutraceuticals techProvider of natural supplements and wellness products
Founded2024Unfunded
Founders
Details not available
Pain managementDeveloper of non-opioid drugs for neuropathic and eye pain treatment
Founded2024Unfunded
Founders
Details not available
Life sciences techPlatform offering solutions for compliance process for medical device regulation
Founded2024Unfunded
Founders
Details not available
GenomicsHome | seqSight
Founded2024Unfunded
Founders
Details not available
Life sciences techDeveloper of therapeutics addressing unmet needs in fibrotic and inflammatory diseases
Founded2024Funding Raised
Founders
Details not available
OrthopedicsProvider of therapeutics for orthopedic indications
Founded2023Series A
Founders · 2
Alessandra Pavesio in ↗Co-Founder & CEO
Sarah Caley in ↗Co-Founder
ImmunologyDeveloper of thymus-based therapies for immune-mediated diseases to increase healthspan
Founded2023Seed
Founders · 2
Holger Russ in ↗Scientific Co-Founder
Francisco LeonFounder,& CEO, Chairman
Life sciences techProvider of AI-powered platform for clinical research participant recruitment workflows
Founded2023Seed
Founders · 2
Saathvik Boompelli in ↗Co-Founder
John Xu in ↗Co-Founder
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- Not available
- Recorded funding
- US$130.00m · Series A · Feb 2026
- Founded
- 2026 · about 0 years old
- Stage
- Series A
- Focus
- Drugs, Pain
Founders · 1
Neil BuckleyCo-Founder & CEO
- Highest education
- MS · Northeastern University
Investors · 3
- ForbionFund
- Foresite CapitalFund
Team & hiring signals
LinkedIn headcount72-10
LinkedIn followers1,001
LinkedIn page Recent company signals
- Leadership Hired a Chief Financial Officer
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- Not available
- Recorded funding
- US$1.12m · Seed · Sep 2025
- Founded
- 2025 · about 1 years old
- Stage
- Seed
- Focus
- Genomics, Research services
Team & hiring signals
LinkedIn headcount1111-50
LinkedIn followers425
LinkedIn page Recent company signals
- Partnership Partnership with Alamar Biosciences, Inc.
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SaaSSocial impactSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$2.00m · Seed · Nov 2025
- Founded
- 2024 · about 2 years old
- Stage
- Seed
- Focus
- Diversified, Research services
Investors · 6
- Alix VenturesFund
IndieBioFund- TerasakiFund
2ndFFund
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 2024 · about 2 years old
- Stage
- Unfunded
- Focus
- Medical devices, Retinal disorders, Therapy
Founders · 2
Steven BacichCo-Founder
- Highest education
- University of California San Diego
Timothy WillisCo-Founder
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Consumer
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 2024 · about 2 years old
- Stage
- Unfunded
- Focus
- Dietary supplements, Disease specific, Diversified
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Consumer
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 2024 · about 2 years old
- Stage
- Unfunded
- Focus
- Diversified, Drugs
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 2024 · about 2 years old
- Stage
- Unfunded
- Focus
- Research & development, Clinical trials, Regulatory solutions, Reporting and compliance
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Artificial Intelligence
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 2024 · about 2 years old
- Stage
- Unfunded
- Focus
- Document search, Genome informatics, Integrative bioinformatics platforms, Internal
Team & hiring signals
LinkedIn headcount12-10
LinkedIn followers53
LinkedIn page Recent company signals
- Award 2nd place at the 2026 Technology Commercialization Office of the George Washington University TCO Innovation Competition, Life Sciences — Ge
- Award GW Technology Commercialization Office (TCO) Innovation Competition — GW Technology Commercialization Office (TCO)
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- Not available
- Recorded funding
- None recorded
- Founded
- 2024 · about 2 years old
- Stage
- Funding Raised
- Focus
- Ai based, Cheminformatics, Diversified, Drug discovery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- Not available
- Recorded funding
- US$11.00m · Series A · Nov 2024
- Founded
- 2023 · about 3 years old
- Stage
- Series A
- Focus
- Drugs, Osteoarthritis
Founders · 2
Alessandra PavesioCo-Founder & CEO
- Highest education
- Chemistry · University Of Torino
Sarah CaleyCo-Founder
- Highest education
- Doctorates in microbiology · University Of North Carolina At Chapel Hill School Of Medicine
Investors · 1
Team & hiring signals
LinkedIn headcount82-10
LinkedIn followers726
Open roles1of 1 tracked · last posted Jan 2026
- Hiring: Clinical Operations professional · Cathleen Hill, NC
Recent company signals
- Milestone dosed first patient in Phase 3 study of MOTYS (PTP-001) first patient dosed in Phase 3 study of MOTYS (PTP-001) for the treatment of knee os
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$37.40m · Seed · Dec 2024
- Founded
- 2023 · about 3 years old
- Stage
- Seed
- Focus
- Diversified, Drugs
Funding over time
US$37.40m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Holger RussScientific Co-Founder
- Highest education
- Doctorates in philosophy · Tel Aviv University
Francisco LeonFounder,& CEO, Chairman
Investors · 6
- BioAdvanceFund
- Columbus Venture PartnersFund
- Sessa CapitalFund
Team & hiring signals
LinkedIn headcount162-10
LinkedIn followers2,283
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Artificial IntelligenceSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- Not available
- Recorded funding
- US$4.30m · Seed · Oct 2025
- Founded
- 2023 · about 3 years old
- Stage
- Seed
- Focus
- Ctms and edc, Clinical trials, Cognitive ai, Conversational ai
Founders · 2
Saathvik BoompelliCo-Founder
- Highest education
- Duke University
John XuCo-Founder
Investors · 8
- Ali RowghaniAngel
- Christophe RimannAngel
- Jack AltmanAngel
- Joshua MillerAngel
- Max CohenAngel
- Sajith WickramasekaraAngel
- Trey HoltermanAngel
Team & hiring signals
LinkedIn headcount102-10
LinkedIn followers873
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Most covered in the news
Companies with the most distinct news events in the last 24 months across the business press Fliar tracks.
Dental disordersDeveloper of dental products and equipment
News events · last 24 months79Across tracked business press
Founders
Details not available
OncologyDeveloper of chemo-protective treatments for cancer patients
News events · last 24 months71Across tracked business press
Leadership · 1
Rostislav RaykovCEO
Rare diseasesDeveloper of small molecule drugs for orphan & autoimmune diseases and antivirals
News events · last 24 months64Across tracked business press
Leadership · 1
NanotechnologyDeveloper of therapeutics for pulmonary hypertension and cardiopulmonary conditions
News events · last 24 months56Across tracked business press
Founders
Details not available
Regenerative medicineProvider of human tissue-based products for vascular disease
News events · last 24 months41Across tracked business press
Founder · 1
Juliana Blum in ↗Co-Founder, Executive Advisor
OrthopedicsManufacturer of healing therapy products
News events · last 24 months36Across tracked business press
Leadership · 1
Ken RealiCEO
PulmonologyDeveloper of therapeutics to address cardiovascular and pulmonary diseases
News events · last 24 months31Across tracked business press
Leadership · 2
John KelleyEx-CEO
Gene therapyDeveloper of gene therapies to treat retinal degenerative diseases
News events · last 24 months31Across tracked business press
Founder · 1
Jason Menzo in ↗Co-Founder
NephrologyDeveloper of therapeutics for the treatment of chronic kidney disease
News events · last 24 months22Across tracked business press
Leadership · 1
ImmunologyDeveloper of small molecules for diabetes, muscle weakness and inflammatory diseases
News events · last 24 months21Across tracked business press
Leadership · 2
Paul Sekhri in ↗CEO & President
Gene therapyDeveloper of gene editing therapies to treat rare genetic diseases
News events · last 24 months16Across tracked business press
Leadership · 1
Life sciences techProvider of clinical research and commercialization solutions for healthcare
News events · last 24 months13Across tracked business press
Founders · 2
Luciano CatoniFounder, Chairman of the Board of Directors
Dennis GillingsFounder
HardwareAcquirer · 1 deal
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 15,000 (previous snapshot 9,206)
- Recorded funding
- None recorded
- Founded
- 1899 · about 127 years old
- Stage
- Public
- Focus
- Medical devices, Therapeutic devices, Diversified
Investors · 1
- Kelso & CompanyFund
Team & hiring signals
LinkedIn headcount11,32610,001+
LinkedIn followers411,626
Earlier recorded team15,0002023, a different source
Open roles6of 51 tracked · last posted Jun 2026
LinkedIn page Patents
Patent filings2364
Focus: Dental imaging, handpieces, impression materials, bone regeneration, and 3D‑printed dental models
CPC A61C13/0004, A61C13/0022, A61C5/50Mobile apps
- DS Core LinkBusiness · 4,148 installs · updated 2026-05-22
- Dentsply Sirona SMA 2.0Business · 2,135 installs · updated 2023-10-13
Technology
- AWS
- React
- Next.js
- Angular
- Node.js
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 36 (previous snapshot 32)
- Recorded funding
- None recorded
- Founded
- 1996 · about 30 years old
- Stage
- Public
- Focus
- Drugs, Therapy complications, Cisplatin induced hearing loss
Leadership · 1
Rostislav RaykovCEO
Team & hiring signals
LinkedIn headcount5911-50
LinkedIn followers10,442
Earlier recorded team362022, a different source
Open roles1of 1 tracked · last posted Jun 2026
- Hiring: Territory Manager
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Acquirer · 1 deal
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 536
- Recorded funding
- None recorded
- Founded
- 1986 · about 40 years old
- Stage
- Public
- Focus
- Drugs, Diversified
Leadership · 1
Jon StonehouseCEO
- Highest education
- Microbiology · University Of Minnesota
Team & hiring signals
LinkedIn headcount611501-1,000
LinkedIn followers51,911
Earlier recorded team5362024, a different source
Open roles1of 4 tracked · last posted Jun 2026
LinkedIn page Technology
- AWS
- PHP
- MySQL
- Cloudflare
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Has made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 63
- Recorded funding
- US$90.30m · Series D · Feb 2018
- Founded
- 2004 · about 22 years old
- Stage
- Public
- Focus
- Nanoparticle based, Nanoenabled products, Life science, Drug delivery
Funding over time
US$75.30m across 5 disclosed equity rounds
Darker bars = larger roundsInvestors · 11
- AmereusFund
- CanaanFund
- Firelake CapitalFund
- MorningsideFund
- Next47Fund
- Pappas CapitalFund
Team & hiring signals
LinkedIn headcount30051-200
LinkedIn followers15,200
Earlier recorded team632022, a different source
Open roles3of 9 tracked · last posted Jun 2026
- Hiring: Territory Account Manager · New York City Metropolitan Area
- Hiring: Lead IT Systems Administrator · Morrisville, North Carolina
- Hiring: Sr. Scientist, Quality Control · Morrisville, North Carolina
Patents
Patent filings120
Focus: Patents concentrated in transport & manufacturing processes
CPC B29C33/3857, B29C35/0805, A61N1/306Technology
- AWS
- PHP
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 70
- Recorded funding
- US$424.76m · Series D · Jun 2018
- Founded
- 2004 · about 22 years old
- Stage
- Public
- Focus
- Diversified, Drugs
Funding over time
US$424.76m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Juliana BlumCo-Founder, Executive Advisor
Investors · 7
- Bangkok BankFund
- Pacific EagleFund
- Reignwood GroupFund
- Brady DouganAngel
Team & hiring signals
LinkedIn headcount159201-500
LinkedIn followers16,756
Earlier recorded team702022, a different source
Open roles1of 3 tracked · last posted Mar 2026
LinkedIn page Patents
Patent filings137
Focus: Engineered vascular grafts and medicated implantable matrices for blood vessel replacement.
CPC C12N5/0068, A61F2/20, A61L27/3633Technology
- AWS
- PHP
- MySQL
- Nginx
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
ConsumerAcquirer · 1 deal
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 950
- Recorded funding
- None recorded
- Founded
- 2012 · about 14 years old
- Stage
- Public
- Focus
- Diversified, Joint reconstruction, Medical devices, Therapies
Leadership · 1
Ken RealiCEO
Investors · 1
Team & hiring signals
LinkedIn headcount1,170501-1,000
LinkedIn followers52,032
LinkedIn page Patents
Patent filings104
Focus: Patents concentrated in chemistry & materials
CPC C01B25/32, A61L27/56, A61N7/00Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 8
- Recorded funding
- None recorded
- Founded
- 1967 · about 59 years old
- Stage
- Public
- Focus
- Drugs, Pulmonary arterial hypertension, Heart failure
Leadership · 2
John KelleyEx-CEO
Chris GiordanoCEO
- Highest education
- Master's in english · University Of North Carolina At Chapel Hill
Team & hiring signals
LinkedIn headcount2411-50
LinkedIn followers4,120
Earlier recorded team82021, a different source
LinkedIn page Recent company signals
- Leadership Hired a CCO
- Leadership Hired a CFO
Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 14 (previous snapshot 31)
- Recorded funding
- US$23.50m · Seed · Jun 2023
- Founded
- 2021 · about 5 years old
- Stage
- Public
- Focus
- Drugs, Retinal disorders
Funding over time
US$23.50m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Jason MenzoCo-Founder
Investors · 3
- Bios PartnersFund
- RD FundFund
Team & hiring signals
LinkedIn headcount4611-50
LinkedIn followers9,127
Open roles1of 2 tracked · last posted Mar 2026
LinkedIn page Patents
Patent filings26
Focus: Pharmaceutical eye‑drop formulations targeting mydriasis, presbyopia, and AMD treatment
CPC A61K31/417, A61K9/0048, C07C57/42Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- Bootstrap
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Has made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 122 (previous snapshot 79)
- Recorded funding
- None recorded
- Founded
- 2018 · about 8 years old
- Stage
- Public
- Focus
- Drugs, Renal disorders
Leadership · 1
Tim BertramCEO
- Highest education
- Iowa State University
Team & hiring signals
LinkedIn headcount23951-200
LinkedIn followers11,198
Open roles4of 12 tracked · last posted May 2026
LinkedIn page Technology
- AWS
- PHP
- MySQL
- Nginx
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 22 (previous snapshot 62)
- Recorded funding
- None recorded
- Founded
- 1999 · about 27 years old
- Stage
- Public
- Focus
- Drugs, Autoimmune diseases, Diversified, Acute kidney diseases
Leadership · 2
Deepa PrasadCEO
- Highest education
- Master's of business administration in management · Northwestern University - Kellogg School Of Management
Paul SekhriCEO & President
- Highest education
- Neuroscience · University Of Maryland School Of Medicine
Investors · 3
CephalonFund
- Novo NordiskFund
Team & hiring signals
LinkedIn headcount6211-50
LinkedIn followers4,758
Earlier recorded team222022, a different source
LinkedIn page Patents
Patent filings321
Focus: Small‑molecule therapeutics for metabolic, hematologic, bone and neurodegenerative diseases.
CPC C07D471/04, A61K31/155, A61K45/06Technology
- PHP
- MySQL
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 236
- Recorded funding
- US$135.65m · Series B · Jun 2018
- Founded
- 2006 · about 20 years old
- Stage
- Public
- Focus
- Enabling technologies, Technology platforms, Gene editing, Drugs
Funding over time
US$135.65m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Matthew KaneCEO
Investors · 20
- Agent CapitalFund
- Aliment CapitalFund
- BaxterFund
- CowenFund
Team & hiring signals
LinkedIn headcount10051-200
LinkedIn followers24,648
Earlier recorded team2362022, a different source
Open roles1of 1 tracked · last posted Mar 2026
LinkedIn page Patents
Patent filings68
Focus: Precise gene editing tools for therapeutic targets and engineered cell therapies
CPC C12N9/22, A61K38/465, C07K14/7151Technology
- AWS
- PHP
- MySQL
- Nginx
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SaaSSoftwareHas made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 87,000 (previous snapshot 586)
- Recorded funding
- None recorded
- Founded
- 1982 · about 44 years old
- Stage
- Public
- Focus
- Research & development, Clinical trials, Patient interaction, Industry specific marketing
Founders · 2
Luciano CatoniFounder, Chairman of the Board of Directors
Dennis GillingsFounder
Investors · 1
- 3i GroupFund
Team & hiring signals
LinkedIn headcount85,80510,001+
LinkedIn followers2,728,991
Earlier recorded team87,0002023, a different source
LinkedIn page Recent company signals
- Partnership Partnership with Gaates Medical Research Institute
Patents
Patent filings219
Focus: Health data analytics and AI-driven clinical trial design, monitoring, and regulatory intelligence.
CPC G16H10/20, G16H10/60, G16H40/20Mobile apps
- IQVIA Study HubHealth & Fitness · 105,417 installs · ★ 3.9 · updated 2026-05-23
- Sales ViewBusiness · 94,435 installs · updated 2022-09-01
- OCEMedical · 11,180 installs · updated 2026-05-20
Technology
- AWS
- Azure
- React
- Next.js
- Angular
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Explore North Carolina life sciences companies by sub-sector
The most common specialisations among life sciences companies in North Carolina. Open a company to see what it sells, who runs it and how far it has come.
Life sciences tech · 74
74 life sciences companies in North Carolina work in life sciences tech. Shown: the best-documented.
GenomicsProvider of services in the development of precision medicine tools for cancer treatment
Revenue modelFee-for-service
Founder · 1
Sizhen Wang in ↗Co-Founder & CEO
Healthcare itProvider of laboratory automation solutions for performing routine tasks in laboratories
Revenue modelSubscription
Founders · 2
Jihoon Baek in ↗Co-Founder & CEO
George Zhao in ↗Founder & COO / Head of Product
Life sciences techOnline platform for analyzing omics clinical data
Revenue modelSubscription
Founders
Details not available
Life sciences techDeveloper of voice-enabled laboratory management systems
Revenue modelSubscription
Founders · 2
Matt Hahn in ↗Founder
Frederic Bost in ↗Founder&CEO
Life sciences techProvider of chemical compound safety tools for healthcare, cosmetic and food industry
Revenue modelFee-for-service
Leadership · 1
Life sciences techCloud based platform to match patients with clinical trials.
Revenue modelSubscription
Founder · 1
Courtney Hudson in ↗Founder & CEO
Quantum computingDeveloper of a AI and quantum computing-based drug discovery platform
Revenue modelSubscription
Founder · 1
Bill Shipman in ↗Co-Founder
Life sciences techThe company provides a full-stack clinical trials platform for community physicians
Revenue modelSubscription
Founders · 3
Andrew Kirchner in ↗Co-Founder
Alexander Saint-Amand in ↗Co-Founder & CEO
Mac Parish in ↗Co-Founder, Product
Life sciences techDeveloper of therapeutics for undruggable targets
Revenue modelPhysical commerce / Subscription
Founders · 4
Mark Hallen in ↗Co-Founder & CTO
Nancy Miller-Rich in ↗Co-Founder
Marcel Frenkel in ↗Co-Founder & CEO
Bruce Donald in ↗Co-Founder
Life sciences techAI-powered drug discovery and development transforming healthcare with generative AI
Revenue modelFee-for-service
Leadership · 1
Ed Addison in ↗Chairman & CEO
Life sciences techDeveloper of microbiome technology to detect infectious diseases
Revenue modelSubscription
Founders · 2
John Fennebresque in ↗Co-Founder & CEO
Mark Spizer in ↗Co-Founder
Life sciences techDeveloper of formulation technology for bio-therapeutics drug delivery
Revenue modelPhysical commerce
Founder · 1
Karen LeVert in ↗Co-Founder & CEO
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 993
- Recorded funding
- US$191.06m · Series D · Nov 2019
- Founded
- 2013 · about 13 years old
- Stage
- Public
- Focus
- Applied genomics, Clinical genomics, Diagnostics, Sequencing-based
Funding over time
US$191.06m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Sizhen WangCo-Founder & CEO
- Highest education
- Master's of business administration in finance · Ecole Des Hautes Etudes Commerciales
Investors · 11
- AlexandriaFund
- CICCFund
- Share CapitalFund
- V Star CapitalFund
Team & hiring signals
LinkedIn headcount96501-1,000
LinkedIn followers1,189
Earlier recorded team9932022, a different source
LinkedIn page Technology
- Nginx
- Bootstrap
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SaaSSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 21
- Recorded funding
- US$4.00m · Seed · Aug 2022
- Founded
- 2018 · about 8 years old
- Stage
- Seed
- Focus
- Research & development, Laboratory management, Laboratory automation, Pathology
Funding over time
US$4.00m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Jihoon BaekCo-Founder & CEO
- Highest education
- The University of North Carolina
George ZhaoFounder & COO / Head of Product
Investors · 2
Tweener FundFund
Team & hiring signals
LinkedIn headcount1811-50
LinkedIn followers1,873
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 21 (previous snapshot 37)
- Recorded funding
- US$27.28m · Series A · May 2024
- Founded
- 2021 · about 5 years old
- Stage
- Series A
- Focus
- Research & development, Drug informatics, Clinical data analysis, Omics analysis
Funding over time
US$27.28m across 2 disclosed equity rounds
Darker bars = larger roundsInvestors · 3
- Anzu PartnersFund
- Genoa VenturesFund
- VC23Fund
Team & hiring signals
LinkedIn headcount2711-50
LinkedIn followers2,217
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SaaSSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 15 (previous snapshot 15)
- Recorded funding
- US$3.70m · Seed · Nov 2024
- Founded
- 2017 · about 9 years old
- Stage
- Seed
- Focus
- Research & development, Laboratory management, Laboratory automation, Pathology
Funding over time
US$3.70m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Matt HahnFounder
- Highest education
- Doctor Of Philosophy (Ph.D.) · UC Santa Cruz
Frederic BostFounder&CEO
Team & hiring signals
LinkedIn headcount112-10
LinkedIn followers2,018
LinkedIn page Mobile apps
- LabVoiceBusiness · 238 installs · updated 2026-05-22
Technology
- AWS
- Google Cloud
- React
- Cloudflare
Sentry
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 15 (previous snapshot 31)
- Recorded funding
- US$90k · Seed · Oct 2020
- Founded
- 2016 · about 10 years old
- Stage
- Seed
- Focus
- Genome informatics, Sequence analysis, Research & development, Drug discovery
Funding over time
US$90k across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Jean OrelienCEO
Team & hiring signals
LinkedIn headcount1911-50
LinkedIn followers1,469
Earlier recorded team152022, a different source
LinkedIn page Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
ConsumerSaaSSocial impactSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 13 (previous snapshot 18)
- Recorded funding
- US$3.00m · Series B · Jan 2006
- Founded
- 2000 · about 26 years old
- Stage
- Series B
- Focus
- Research & development, Clinical trials, Scientific sourcing, Patients
Founders · 1
Courtney HudsonFounder & CEO
- Highest education
- Yale University
Investors · 4
- Rand CapitalFund
- Spring BayFund
Technology
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 13 (previous snapshot 20)
- Recorded funding
- US$2.48m · Seed · Aug 2021
- Founded
- 2019 · about 7 years old
- Stage
- Seed
- Focus
- Applications, Life sciences, Research & development, Drug discovery
Funding over time
US$2.48m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Bill ShipmanCo-Founder
Team & hiring signals
LinkedIn headcount92-10
LinkedIn followers2,018
Earlier recorded team132022, a different source
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 12 (previous snapshot 34)
- Recorded funding
- US$27.50m · Series A · Jan 2022
- Founded
- 2020 · about 6 years old
- Stage
- Series A
- Focus
- Training platforms, Clinical research
Funding over time
US$27.50m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 3
Andrew KirchnerCo-Founder
- Highest education
- Doctor of jurisprudence in law · Columbia Law School
Alexander Saint-AmandCo-Founder & CEO
- Highest education
- Bachelor's of Arts · University of Virginia
Mac ParishCo-Founder, Product
- Highest education
- Master's of business administration · Stanford University Graduate School Of Business
Investors · 5
- Spencer RascoffAngel
- Tom LeeAngel
- Bobby GreenAngel
Team & hiring signals
LinkedIn headcount3051-200
LinkedIn followers5,184
Earlier recorded team122021, a different source
Open roles2of 11 tracked · last posted Jan 2026
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce, Subscription
- Team size
- 10 (previous snapshot 10)
- Recorded funding
- US$18.30m · Series A · Feb 2026
- Founded
- 2019 · about 7 years old
- Stage
- Series A
- Focus
- Research & development, Drug discovery, Cheminformatics, Lead discovery
Funding over time
US$18.30m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 4
Mark HallenCo-Founder & CTO
- Highest education
- Bachelor's in mathematics · Duke University
Nancy Miller-RichCo-Founder
Marcel FrenkelCo-Founder & CEO
- Highest education
- Doctorates in biochemistry · Duke University
Bruce DonaldCo-Founder
- Highest education
- Computer Science · Massachusetts Institute Of Technology
Investors · 16
- AlexandriaFund
- Duke UniversityFund
- IndieBioFund
Team & hiring signals
LinkedIn headcount3211-50
LinkedIn followers4,585
Open roles1of 1 tracked · last posted Nov 2025
- Hiring: Principal Scientific Engineer · Dublin, North Carolina
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SaaSSoftware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 5
- Recorded funding
- US$3.35m · Series A · Jul 2015
- Founded
- 2009 · about 17 years old
- Stage
- Series A
- Focus
- Research & development, Drug discovery, Cheminformatics
Funding over time
US$3.35m across 4 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Ed AddisonChairman & CEO
Team & hiring signals
LinkedIn headcount511-50
LinkedIn followers1,228
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 4
- Recorded funding
- US$5.55m · Series A · Sep 2022
- Founded
- 2015 · about 11 years old
- Stage
- Series A
- Focus
- Genome informatics, Integrative bioinformatics platforms, Research & development, Drug discovery
Funding over time
US$5.55m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 2
John FennebresqueCo-Founder & CEO
- Highest education
- Master's of business administration in financial management · Columbia Business School
Mark SpizerCo-Founder
- Highest education
- Bachelor's in economics · Florida State University
Patents
Patent filings30
Focus: Targeted amplicon sequencing for disease diagnostics and microbial‑based therapeutic composition design.
CPC G16B5/00, G16B30/20, A61K35/74Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 4
- Recorded funding
- US$7.26m · Series B · Mar 2024
- Founded
- 2016 · about 10 years old
- Stage
- Series B
- Focus
- Research & development, Drug formulation
Funding over time
US$7.26m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Karen LeVertCo-Founder & CEO
- Highest education
- BS · Eastern Michigan University
Investors · 2
Team & hiring signals
LinkedIn headcount2411-50
LinkedIn followers1,456
Earlier recorded team42019, a different source
LinkedIn page Technology
- Google Cloud
- React
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Life sciences platforms and tools · 71
71 life sciences companies in North Carolina work in life sciences platforms and tools. Shown: the best-documented.
Life sciences platforms and toolsDevelops assays and research tools for specific biological systems
Revenue modelPhysical commerce / Subscription
Founder · 1
Peyton Anderson in ↗Founder & CEO
OncologyDeveloper of drug discovery and precision therapy platform for oncology
Revenue modelSubscription
Founder · 1
Hans CleversCo-Founder
Life sciences platforms and toolsProvider of epigentic kits, reagents and assays for research purpose
Revenue modelPhysical commerce
Founders · 4
Jim BoneCo-Founder & President
Brian D. Strahl in ↗Co-Founder
Or Gozani in ↗Co-Founder
Mark BedfordFounder
NanotechnologyElectron microscopy products and analytical tools for studying nanoscale materials
Revenue modelPhysical commerce
Founders · 2
David Nackashi in ↗Co-Founder & CEO
John Damiano in ↗CTO & Co-Founder
Life sciences platforms and toolsSample preparation tools for microbiology research
Revenue modelSubscription
Leadership · 1
Life sciences platforms and toolsProvider of invitro platform for drug testing
Revenue modelPhysical commerce
Founders · 5
Scott Magness in ↗Co-Founder
Nancy Allbritton in ↗Co-Founder
Michael Biron in ↗Co-Founder & CEO
Yuli WangCo-Founder & CSO
Christopher Sims Md in ↗Founder, Principle Investigator and Board Member
Life sciences platforms and toolsDeveloper of a technology to isolate and recover single cells for molecular analysis
Revenue modelSubscription
Leadership · 1
GenomicsProvider RNA-targeted drug discovery platform
Revenue modelSubscription
Founder · 1
Katie Warner in ↗Co-Founder
Life sciences platforms and toolsDeveloper of a genome sequencing and amplification system
Revenue modelSubscription
Founders · 2
Jay West in ↗Co-Founder & CEO
Charles Gawad in ↗Co-Founder
Micro electro mechanical systemsManufacturer of microfluidic platforms for biosensing and sample processing
Revenue modelE-commerce - product / Physical commerce
Founder · 1
Ricky Spero in ↗Founder & CEO
Life sciences platforms and toolsCytology solutions: sample collection, preservation, slide preparation, and digital evaluation
Revenue modelFee-for-service
Leadership · 1
Ernest KneselCEO & President
Life sciences platforms and toolsAdvanced biomaterials company focused on creating keratin-based products for use in areas of regenerative medicine and trauma care
Revenue modelE-commerce - product / Physical commerce
Founders
Details not available
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce, Subscription
- Team size
- 193
- Recorded funding
- US$5.00m · Series B · Mar 2006
- Founded
- 2004 · about 22 years old
- Stage
- Series B
- Focus
- Research assays, Drug discovery
Funding over time
US$5.00m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Peyton AndersonFounder & CEO
- Highest education
- Master's of Business Administration · UNC Kenan-Flagler Business School
Investors · 4
NC IDEAFund
Trinity Healthcare DevelopmentFund
Patents
Patent filings97
Focus: Protein diagnostics, peptide-coated device drug delivery, and biomaterial tissue repair technologies.
CPC A61L27/227, A61K47/64, C07K14/001Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 72
- Recorded funding
- US$116.26m · Series B · Apr 2025
- Founded
- 2019 · about 7 years old
- Stage
- Series B
- Focus
- Research assays, Drug discovery, Organoid models, Patient derived cancer cell models
Funding over time
US$116.26m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Hans CleversCo-Founder
Investors · 14
- AlexandriaFund
- Alix VenturesFund
- Duke UniversityFund
- EQTFund
- FPV VenturesFund
- Felicis VenturesFund
Team & hiring signals
LinkedIn headcount1051-200
LinkedIn followers7,314
Open roles0of 2 tracked · last posted Jul 2025
LinkedIn page Patents
Patent filings97
Focus: Microfluidic organoid droplet generation and component delivery for personalized medicine
CPC B01L3/502784, C12N5/0693, G01N33/5011Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 43 (previous snapshot 52)
- Recorded funding
- US$3.43m · Series A · Jun 2024
- Founded
- 2012 · about 14 years old
- Stage
- Series A
- Focus
- Research reagents and kits, Epigenetics
Funding over time
US$3.43m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 4
Jim BoneCo-Founder & President
Brian D. StrahlCo-Founder
Or GozaniCo-Founder
- Highest education
- Doctor of medicine · Harvard Medical School
Mark BedfordFounder
Team & hiring signals
LinkedIn headcount5211-50
LinkedIn followers4,085
Open roles2of 2 tracked · last posted May 2026
LinkedIn page Patents
Patent filings66
Focus: Chromatin profiling tools: nucleosome barcoding, modification quantification, and high‑throughput assays
CPC G01N33/6875, C12Q1/6804, C12Q1/6806Technology
- PHP
- MySQL
- Cloudflare
Stripe- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SoftwareHardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 40 (previous snapshot 59)
- Recorded funding
- US$3.68m · Series A · May 2019
- Founded
- 2002 · about 24 years old
- Stage
- Series A
- Focus
- Research and development, Microscopy, Electron microscope, Tem
Funding over time
US$3.68m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 2
David NackashiCo-Founder & CEO
- Highest education
- Master's in electrical engineering · North Carolina State University
John DamianoCTO & Co-Founder
Team & hiring signals
LinkedIn headcount4451-200
LinkedIn followers5,379
Earlier recorded team402022, a different source
Open roles0of 1 tracked · last posted Jul 2025
LinkedIn page Patents
Patent filings182
Focus: In situ TEM instrumentation for drift correction, temperature control, and electrochemical analysis
CPC H01J37/20, H04N23/695, H01R13/24Technology
- PHP
- MySQL
- WordPress
- Bootstrap
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
HardwareHas made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 37 (previous snapshot 29)
- Recorded funding
- US$2.71m · Series A · Dec 2025
- Founded
- 2009 · about 17 years old
- Stage
- Series A
- Focus
- Instruments, Lab automation, Sample preparation
Funding over time
US$2.71m across 3 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Dave AlburtyCEO
- Highest education
- Master's of science, Chemical Engineering · The University Of Kansas
Team & hiring signals
LinkedIn headcount2311-50
LinkedIn followers1,050
Earlier recorded team372022, a different source
LinkedIn page Recent company signals
- Award BioTools Innovator Best Video Award
- Award 2025 BioTools Innovator cohort
Patents
Patent filings111
Focus: Disposable fluid-path devices for concentrating biological particles in liquids and aerosols
CPC G01N1/4077, B01D19/0073, G01N1/40Technology
- Cloudflare
- HubSpot
Shopify- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 29 (previous snapshot 26)
- Recorded funding
- US$7.53m · Seed · Mar 2025
- Founded
- 2015 · about 11 years old
- Stage
- Seed
- Focus
- Research assays, Cell based assays, Toxicity assays
Funding over time
US$7.53m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 5
Scott MagnessCo-Founder
- Highest education
- BS · University of California San Diego
Nancy AllbrittonCo-Founder
- Highest education
- BS · Louisiana State University
Michael BironCo-Founder & CEO
- Highest education
- MBA · UNC Kenan-Flagler Business School
Yuli WangCo-Founder & CSO
Christopher Sims MdFounder, Principle Investigator and Board Member
- Highest education
- Biology · Uc Irvine
Investors · 5
- RTP CapitalFund
- VentureSouthFund
Team & hiring signals
LinkedIn headcount2911-50
LinkedIn followers7,485
LinkedIn page Technology
- Cloudflare
- HubSpot
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
HardwareHas made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 28 (previous snapshot 27)
- Recorded funding
- US$19.10m · Series B · Aug 2023
- Founded
- 2009 · about 17 years old
- Stage
- Series B
- Focus
- Instruments, Cell biology, Cell sorting
Funding over time
US$19.10m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Gary PaceCEO
Investors · 2
Team & hiring signals
LinkedIn headcount2111-50
LinkedIn followers2,101
LinkedIn page Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 26 (previous snapshot 34)
- Recorded funding
- US$65.30m · Series A · Sep 2019
- Founded
- 2016 · about 10 years old
- Stage
- Series A
- Focus
- Applied genomics, Clinical genomics, Therapeutics, Research assays
Funding over time
US$65.30m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Katie WarnerCo-Founder
Investors · 12
- AbbVieFund
- AlexandriaFund
- M VenturesFund
- Pappas CapitalFund
Team & hiring signals
LinkedIn headcount2111-50
LinkedIn followers3,907
Earlier recorded team262022, a different source
LinkedIn page Patents
Patent filings9
Focus: eIF4E inhibitor small molecules for oncology therapeutics
CPC C07D239/90, C07D471/04, A61P35/00Technology
- AWS
- PHP
- MySQL
- Nginx
- Cloudflare
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 21 (previous snapshot 59)
- Recorded funding
- US$11.50m · Seed · Jan 2020
- Founded
- 2018 · about 8 years old
- Stage
- Seed
- Focus
- Instruments, Genomics, Nucleic acid sequencing, Enabling technologies
Founders · 2
Jay WestCo-Founder & CEO
Charles GawadCo-Founder
- Highest education
- Doctorates in biology · Stanford University
Investors · 2
- Anzu PartnersFund
Team & hiring signals
LinkedIn headcount4051-200
LinkedIn followers6,305
Earlier recorded team212021, a different source
LinkedIn page Recent company signals
- Launch Launched ResolveOMETM Stability Buffer (SB) Reagent (single-cell or low-input multiomic chemistry sample collection and storage)
Patents
Patent filings8
Focus: High‑sensitivity nucleic‑acid amplification and single‑cell genomic analysis technologies
CPC C12Y207/07007, C12Q1/6806, C12Q1/70Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 20 (previous snapshot 27)
- Recorded funding
- US$305k · Series A · Jan 2021
- Founded
- 2010 · about 16 years old
- Stage
- Series A
- Focus
- Instruments, Microfluidics, Actuators, Microfluidics & biochips
Founders · 1
Ricky SperoFounder & CEO
- Highest education
- PhD · The University of North Carolina
Investors · 1
- VentureSouthFund
Team & hiring signals
LinkedIn headcount2611-50
LinkedIn followers883
Earlier recorded team202022, a different source
LinkedIn page Patents
Patent filings101
Focus: Patents concentrated in transport & manufacturing processes
CPC B01L3/502746, B01L3/50273, B01L3/502761Technology
- PHP
- MySQL
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 16
- Recorded funding
- US$1.90m · Series A · Jul 2018
- Founded
- 2007 · about 19 years old
- Stage
- Series A
- Focus
- Research services, Analytical testing
Funding over time
US$1.90m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Ernest KneselCEO & President
Team & hiring signals
LinkedIn headcount2311-50
LinkedIn followers1,513
LinkedIn page Patents
Patent filings4
Focus: Automated cell sample preparation devices for biomedical analysis
CPC G01N1/2813Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Consumer
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 14 (previous snapshot 24)
- Recorded funding
- US$14.42m · Series A · Feb 2017
- Founded
- 2008 · about 18 years old
- Stage
- Series A
- Focus
- Research services, Diversified, Drugs
Funding over time
US$14.42m across 4 disclosed equity rounds
Darker bars = larger roundsTeam & hiring signals
LinkedIn headcount1511-50
LinkedIn followers410
Earlier recorded team142020, a different source
LinkedIn page Patents
Patent filings37
Focus: Keratin extraction and formulation for veterinary wound care and related biomaterial products.
CPC A61K47/42, A61K8/65, C07K1/36Technology
- PHP
- MySQL
- Cloudflare
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Genomics · 57
57 life sciences companies in North Carolina work in genomics. Shown: the best-documented.
GenomicsProvider of services in the development of precision medicine tools for cancer treatment
Revenue modelFee-for-service
Founder · 1
Sizhen Wang in ↗Co-Founder & CEO
Gene therapyDeveloper of gene editing therapies to treat rare genetic diseases
Revenue modelE-commerce - product / Physical commerce
Leadership · 1
Metabolic diseasesProvider of solutions for biomarker discovery, diagnostic tests and personalized medicine
Revenue modelSubscription
Founder · 1
John Ryals in ↗Ex-Founder
GenomicsProvider of gene editing technology for climate-resilient, nutritious, and sustainable crops
Revenue modelE-commerce - product / Physical commerce
Leadership · 1
GenomicsDeveloper of AAV based gene therapies for rare diseases
Revenue modelSubscription
Founders · 3
Aravind Asokan in ↗Co-Founder
Mavis Agbandje-McKennaCo-Founder & Director
Patrick Ritschel in ↗Co-Founder
Infectious diseasesDeveloper of therapeutics for infectious disease and inflammatory indications
Revenue modelE-commerce - product / Physical commerce
Founders
Details not available
OncologyDeveloper of drug discovery and precision therapy platform for oncology
Revenue modelSubscription
Founder · 1
Hans CleversCo-Founder
GenomicsProvider RNA-targeted drug discovery platform
Revenue modelSubscription
Founder · 1
Katie Warner in ↗Co-Founder
GenomicsDeveloper of a predictive breeding platform to identify crop traits and build crop models
Revenue modelPhysical commerce / Subscription
Founders · 2
Spencer Maughan in ↗Co-Founder & Chairman
Philip Benfey in ↗Co-Founder & Chairman
Life sciences platforms and toolsDeveloper of a genome sequencing and amplification system
Revenue modelSubscription
Founders · 2
Jay West in ↗Co-Founder & CEO
Charles Gawad in ↗Co-Founder
Life sciences techOnline platform for analyzing omics clinical data
Revenue modelSubscription
Founders
Details not available
GenomicsDeveloper of diagnostics for cancer classification and treatment
Revenue modelSubscription
Founders
Details not available
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 993
- Recorded funding
- US$191.06m · Series D · Nov 2019
- Founded
- 2013 · about 13 years old
- Stage
- Public
- Focus
- Applied genomics, Clinical genomics, Diagnostics, Sequencing-based
Funding over time
US$191.06m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Sizhen WangCo-Founder & CEO
- Highest education
- Master's of business administration in finance · Ecole Des Hautes Etudes Commerciales
Investors · 11
- AlexandriaFund
- CICCFund
- Share CapitalFund
- V Star CapitalFund
Team & hiring signals
LinkedIn headcount96501-1,000
LinkedIn followers1,189
Earlier recorded team9932022, a different source
LinkedIn page Technology
- Nginx
- Bootstrap
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 236
- Recorded funding
- US$135.65m · Series B · Jun 2018
- Founded
- 2006 · about 20 years old
- Stage
- Public
- Focus
- Enabling technologies, Technology platforms, Gene editing, Drugs
Funding over time
US$135.65m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Matthew KaneCEO
Investors · 20
- Agent CapitalFund
- Aliment CapitalFund
- BaxterFund
- CowenFund
Team & hiring signals
LinkedIn headcount10051-200
LinkedIn followers24,648
Earlier recorded team2362022, a different source
Open roles1of 1 tracked · last posted Mar 2026
LinkedIn page Patents
Patent filings68
Focus: Precise gene editing tools for therapeutic targets and engineered cell therapies
CPC C12N9/22, A61K38/465, C07K14/7151Technology
- AWS
- PHP
- MySQL
- Nginx
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SoftwareHas made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 189 (previous snapshot 311)
- Recorded funding
- US$165.87m · Series H · Dec 2024
- Founded
- 2000 · about 26 years old
- Stage
- Series H
- Focus
- In vitro diagnostic tests, Inborn errors of metabolism, Genomics research, Biomarker discovery
Funding over time
US$165.87m across 15 disclosed equity rounds
Darker bars = larger roundsFounders · 1
John RyalsEx-Founder
Investors · 12
- AlexandriaFund
- Camden PartnersFund
- Fletcher SpaghtFund
- Sevin RosenFund
- The Aurora FundsFund
Team & hiring signals
LinkedIn headcount203201-500
LinkedIn followers22,872
Earlier recorded team1892022, a different source
Open roles4of 8 tracked · last posted Apr 2026
LinkedIn page Patents
Patent filings400
Focus: Metabolomics biomarker discovery and diagnostic assays for metabolic and inflammatory diseases
CPC G01N33/6893, G01N33/92, G01N33/6848Technology
- PHP
- MySQL
- Cloudflare
- HubSpot
- Salesforce
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 163 (previous snapshot 158)
- Recorded funding
- US$155.00m · Series C · Sep 2024
- Founded
- 2017 · about 9 years old
- Stage
- Series C
- Focus
- Applied genomics, Agrigenomics, Farm inputs, Seeds
Funding over time
US$155.00m across 3 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Tom AdamsCEO
Investors · 6
- Aliment CapitalFund
- DeerfieldFund
- Leaps by BayerFund
- MonsantoFund
- TemasekFund
Team & hiring signals
LinkedIn headcount11551-200
LinkedIn followers18,199
Open roles1of 1 tracked · last posted Jun 2026
- Internship: 2026 Summer Intern
Recent company signals
- Partnership Partnership with Pipewise
Technology
- Cloudflare
- HubSpot
- Webflow
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 109 (previous snapshot 120)
- Recorded funding
- US$98.20m · Series B · Mar 2021
- Founded
- 2015 · about 11 years old
- Stage
- Series B
- Focus
- Drugs, Diversified, Enabling technologies, Technology platforms
Funding over time
US$98.20m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 3
Aravind AsokanCo-Founder
- Highest education
- Virology · University Of North Carolina At Chapel Hill School Of Medicine
Mavis Agbandje-McKennaCo-Founder & Director
Patrick RitschelCo-Founder
- Highest education
- Bachelor's in mechanical engineering · University Of Illinois At Urbana - Champaign
Investors · 12
- AlexandriaFund
- Novo HoldingsFund
- PontifaxFund
- SareptaFund
Team & hiring signals
LinkedIn headcount451-200
LinkedIn followers5,067
Earlier recorded team1092022, a different source
LinkedIn page Patents
Patent filings89
Focus: Recombinant AAV vector design, manufacturing, and gene‑therapy delivery platforms
CPC C12N15/86, C07K14/005, C07K14/47Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Has made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 74 (previous snapshot 104)
- Recorded funding
- US$67.33m · Series B · May 2022
- Founded
- 2015 · about 11 years old
- Stage
- Series B
- Focus
- Enabling technologies, Technology platforms, Gene editing, Drugs
Funding over time
US$67.33m across 5 disclosed equity rounds
Darker bars = larger roundsInvestors · 7
- Artis VenturesFund
- IlluminaFund
- NCBiotechFund
- TencentFund
Team & hiring signals
LinkedIn headcount5551-200
LinkedIn followers9,083
Earlier recorded team742022, a different source
Open roles0of 3 tracked · last posted Aug 2025
LinkedIn page Recent company signals
- Partnership Partnership with Viatris
Patents
Patent filings60
Focus: Engineered CRISPR‑enhanced bacteriophage therapeutics targeting antibiotic‑resistant bacterial infections
CPC C12N15/74, A61K35/76, C12N7/00Technology
- PHP
- MySQL
- Nginx
- Cloudflare
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 72
- Recorded funding
- US$116.26m · Series B · Apr 2025
- Founded
- 2019 · about 7 years old
- Stage
- Series B
- Focus
- Research assays, Drug discovery, Organoid models, Patient derived cancer cell models
Funding over time
US$116.26m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Hans CleversCo-Founder
Investors · 14
- AlexandriaFund
- Alix VenturesFund
- Duke UniversityFund
- EQTFund
- FPV VenturesFund
- Felicis VenturesFund
Team & hiring signals
LinkedIn headcount1051-200
LinkedIn followers7,314
Open roles0of 2 tracked · last posted Jul 2025
LinkedIn page Patents
Patent filings97
Focus: Microfluidic organoid droplet generation and component delivery for personalized medicine
CPC B01L3/502784, C12N5/0693, G01N33/5011Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 26 (previous snapshot 34)
- Recorded funding
- US$65.30m · Series A · Sep 2019
- Founded
- 2016 · about 10 years old
- Stage
- Series A
- Focus
- Applied genomics, Clinical genomics, Therapeutics, Research assays
Funding over time
US$65.30m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Katie WarnerCo-Founder
Investors · 12
- AbbVieFund
- AlexandriaFund
- M VenturesFund
- Pappas CapitalFund
Team & hiring signals
LinkedIn headcount2111-50
LinkedIn followers3,907
Earlier recorded team262022, a different source
LinkedIn page Patents
Patent filings9
Focus: eIF4E inhibitor small molecules for oncology therapeutics
CPC C07D239/90, C07D471/04, A61P35/00Technology
- AWS
- PHP
- MySQL
- Nginx
- Cloudflare
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Software
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce, Subscription
- Team size
- 24 (previous snapshot 17)
- Recorded funding
- US$8.50m · Series A · Dec 2018
- Founded
- 2014 · about 12 years old
- Stage
- Series A
- Focus
- Farm inputs, Plant breeding, Management solutions, Analytics
Founders · 2
Spencer MaughanCo-Founder & Chairman
Philip BenfeyCo-Founder & Chairman
- Highest education
- Doctorates in biology · Harvard University
Investors · 7
- GRO AllianceFund
- KdT VenturesFund
- S2G VenturesFund
- Tom FarmsFund
Team & hiring signals
LinkedIn headcount52-10
LinkedIn followers516
Earlier recorded team242021, a different source
LinkedIn page Patents
Patent filings37
Focus: Non‑invasive root phenotyping for agricultural plant imaging and phenomics
CPC G01N33/0098, C12Q1/6895, G01N21/84Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 21 (previous snapshot 59)
- Recorded funding
- US$11.50m · Seed · Jan 2020
- Founded
- 2018 · about 8 years old
- Stage
- Seed
- Focus
- Instruments, Genomics, Nucleic acid sequencing, Enabling technologies
Founders · 2
Jay WestCo-Founder & CEO
Charles GawadCo-Founder
- Highest education
- Doctorates in biology · Stanford University
Investors · 2
- Anzu PartnersFund
Team & hiring signals
LinkedIn headcount4051-200
LinkedIn followers6,305
Earlier recorded team212021, a different source
LinkedIn page Recent company signals
- Launch Launched ResolveOMETM Stability Buffer (SB) Reagent (single-cell or low-input multiomic chemistry sample collection and storage)
Patents
Patent filings8
Focus: High‑sensitivity nucleic‑acid amplification and single‑cell genomic analysis technologies
CPC C12Y207/07007, C12Q1/6806, C12Q1/70Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 21 (previous snapshot 37)
- Recorded funding
- US$27.28m · Series A · May 2024
- Founded
- 2021 · about 5 years old
- Stage
- Series A
- Focus
- Research & development, Drug informatics, Clinical data analysis, Omics analysis
Funding over time
US$27.28m across 2 disclosed equity rounds
Darker bars = larger roundsInvestors · 3
- Anzu PartnersFund
- Genoa VenturesFund
- VC23Fund
Team & hiring signals
LinkedIn headcount2711-50
LinkedIn followers2,217
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Has made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 19 (previous snapshot 22)
- Recorded funding
- US$26.86m · Series C · Jun 2025
- Founded
- 2011 · about 15 years old
- Stage
- Series C
- Focus
- Applied genomics, Clinical genomics, Therapeutics, In-vitro diagnostic tests
Funding over time
US$26.86m across 5 disclosed equity rounds
Darker bars = larger roundsInvestors · 5
- AlexandriaFund
- LabCorpFund
- Alexandria Venture InvestmentsFund
Team & hiring signals
LinkedIn headcount1411-50
LinkedIn followers2,216
LinkedIn page Technology
- PHP
- MySQL
- Cloudflare
- Salesforce
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Oncology · 35
35 life sciences companies in North Carolina work in oncology. Shown: the best-documented.
Gene therapyDeveloper of gene editing therapies to treat rare genetic diseases
Revenue modelE-commerce - product / Physical commerce
Leadership · 1
OncologyDeveloper of drug discovery and precision therapy platform for oncology
Revenue modelSubscription
Founder · 1
Hans CleversCo-Founder
ImmunotherapyDeveloper of viral vaccines and antibody drug conjugates for the treatment of cancer
Revenue modelE-commerce - product / Physical commerce
Founders · 2
Matthias GromeierFounder
Darell BignerFounder
ImmunotherapyManufacturer of cytokine agents for treating cancer
Revenue modelFee-for-service
Leadership · 1
Charles NicoletteCEO
GenomicsDeveloper of diagnostics for cancer classification and treatment
Revenue modelSubscription
Founders
Details not available
OncologyAffordable prescription drugs online, bridging the gap for US customers
Revenue modelPhysical commerce
Leadership · 1
OncologyProvider of liquid biopsy tests using CTCs
Revenue modelSubscription
Founder · 1
Steven SoperCo-Founder & CTO
OncologyDeveloper of a medical device used for chemotherapy
Revenue modelE-commerce - product / Physical commerce
Leadership · 1
ImmunotherapyA next-generation cell cycle control company advancing precision treatments for cancer
Revenue modelPhysical commerce
Founders · 4
Patrick Roberts in ↗Co-Founder & CEO
Jay Strum in ↗Co-Founder
John Bisi in ↗Co-Founder
Fred Eshelman in ↗Co-Founder
OncologyProvider of polymer-based devices for localized low dose radiation therapy or brachytherapy
Revenue modelPhysical commerce
Leadership · 1
DermatologyDiagnostic company that develops non-invasive biomarker tests to measure cellular aging and predict the risk of age-related diseases
Revenue modelFee-for-service
Founders · 2
Norman SharplessCo-Founder
Natalia Mitin in ↗Co-Founder & CEO
Life sciences platforms and toolsDeveloper of therapeutic antibodies
Revenue modelPhysical commerce
Founder · 1
Edward Patz in ↗Co-Founder & CEO
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 236
- Recorded funding
- US$135.65m · Series B · Jun 2018
- Founded
- 2006 · about 20 years old
- Stage
- Public
- Focus
- Enabling technologies, Technology platforms, Gene editing, Drugs
Funding over time
US$135.65m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Matthew KaneCEO
Investors · 20
- Agent CapitalFund
- Aliment CapitalFund
- BaxterFund
- CowenFund
Team & hiring signals
LinkedIn headcount10051-200
LinkedIn followers24,648
Earlier recorded team2362022, a different source
Open roles1of 1 tracked · last posted Mar 2026
LinkedIn page Patents
Patent filings68
Focus: Precise gene editing tools for therapeutic targets and engineered cell therapies
CPC C12N9/22, A61K38/465, C07K14/7151Technology
- AWS
- PHP
- MySQL
- Nginx
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 72
- Recorded funding
- US$116.26m · Series B · Apr 2025
- Founded
- 2019 · about 7 years old
- Stage
- Series B
- Focus
- Research assays, Drug discovery, Organoid models, Patient derived cancer cell models
Funding over time
US$116.26m across 5 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Hans CleversCo-Founder
Investors · 14
- AlexandriaFund
- Alix VenturesFund
- Duke UniversityFund
- EQTFund
- FPV VenturesFund
- Felicis VenturesFund
Team & hiring signals
LinkedIn headcount1051-200
LinkedIn followers7,314
Open roles0of 2 tracked · last posted Jul 2025
LinkedIn page Patents
Patent filings97
Focus: Microfluidic organoid droplet generation and component delivery for personalized medicine
CPC B01L3/502784, C12N5/0693, G01N33/5011Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 47 (previous snapshot 56)
- Recorded funding
- US$48.59m · Series B · Apr 2021
- Founded
- 2014 · about 12 years old
- Stage
- Series B
- Focus
- Drugs, Diversified, Viral
Funding over time
US$48.59m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 2
Matthias GromeierFounder
Darell BignerFounder
Team & hiring signals
LinkedIn headcount42-10
LinkedIn followers3,393
Earlier recorded team472021, a different source
LinkedIn page Patents
Patent filings7
Focus: Oncolytic chimeric poliovirus therapies for glioblastoma and intravesical bladder cancer treatment
CPC A61K35/768, A61P35/00Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Has made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 47 (previous snapshot 47)
- Recorded funding
- US$45.00m · Series A · Nov 2020
- Founded
- 2019 · about 7 years old
- Stage
- Series A
- Focus
- Drugs, Diversified
Leadership · 1
Charles NicoletteCEO
Investors · 1
- Lucio RovatiAngel
Patents
Patent filings55
Focus: Patents concentrated in chemistry & materials
CPC C12N5/0639, G01N33/56972, C12N9/0002Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Has made acquisitions
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 19 (previous snapshot 22)
- Recorded funding
- US$26.86m · Series C · Jun 2025
- Founded
- 2011 · about 15 years old
- Stage
- Series C
- Focus
- Applied genomics, Clinical genomics, Therapeutics, In-vitro diagnostic tests
Funding over time
US$26.86m across 5 disclosed equity rounds
Darker bars = larger roundsInvestors · 5
- AlexandriaFund
- LabCorpFund
- Alexandria Venture InvestmentsFund
Team & hiring signals
LinkedIn headcount1411-50
LinkedIn followers2,216
LinkedIn page Technology
- PHP
- MySQL
- Cloudflare
- Salesforce
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
ConsumerSocial impact
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 19
- Recorded funding
- US$42.10m · Series D · Jul 2017
- Founded
- 2014 · about 12 years old
- Stage
- Series D
- Focus
- Drugs, Pan cancer
Funding over time
US$42.10m across 3 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Fred EshelmanCEO
Investors · 6
- Lilly VenturesFund
- Fred EshelmanAngel
Team & hiring signals
LinkedIn headcount12-10
LinkedIn followers341
Earlier recorded team192022, a different source
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Subscription
- Team size
- 13 (previous snapshot 16)
- Recorded funding
- US$18.12m · Series B · Dec 2021
- Founded
- 2007 · about 19 years old
- Stage
- Series B
- Focus
- Applied genomics, Clinical genomics, Diagnostics, Sequencing-based
Funding over time
US$18.12m across 4 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Steven SoperCo-Founder & CTO
Team & hiring signals
LinkedIn headcount711-50
LinkedIn followers1,427
Earlier recorded team132022, a different source
LinkedIn page Patents
Patent filings20
Focus: Microfluidic platforms for high‑efficiency isolation of biomarker and fetal cells.
CPC B01L3/0237, B01L3/502753, G01N35/1011Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- E-commerce - product, Physical commerce
- Team size
- 12 (previous snapshot 12)
- Recorded funding
- US$8.00m · Series A · Feb 2021
- Founded
- 2014 · about 12 years old
- Stage
- Series A
- Focus
- Medical devices, Therapies, Chemotherapy
Funding over time
US$8.00m across 2 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Tony VoiersCEO
- Highest education
- Chemical Engineering · North Carolina State University
Investors · 2
Khosla VenturesFund- SpectrumfinancialFund
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 6 (previous snapshot 6)
- Recorded funding
- US$46.25m · Series B · Apr 2026
- Founded
- 2020 · about 6 years old
- Stage
- Series B
- Focus
- Drugs, Diversified
Funding over time
US$46.25m across 3 disclosed equity rounds
Darker bars = larger roundsFounders · 4
Patrick RobertsCo-Founder & CEO
- Highest education
- The University of North Carolina
Jay StrumCo-Founder
- Highest education
- PhD · Wake Forest University
John BisiCo-Founder
- Highest education
- Bachelor's of Science · NC State University
Fred EshelmanCo-Founder
Investors · 7
- Boxer CapitalFund
- LillyFund
- PharmacosmosFund
Team & hiring signals
LinkedIn headcount132-10
LinkedIn followers1,691
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hardware
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 6
- Recorded funding
- US$12.40m · Series A · Nov 2021
- Founded
- 2006 · about 20 years old
- Stage
- Series A
- Focus
- Medical devices, Therapies, Radiation therapy, Brachytherapy
Funding over time
US$12.40m across 8 disclosed equity rounds
Darker bars = larger roundsLeadership · 1
Suzanne BabcockCEO
Team & hiring signals
LinkedIn headcount511-50
LinkedIn followers513
LinkedIn page Patents
Patent filings23
Focus: Microencapsulated, bioabsorbable brachytherapy sources for precise internal radiation therapy
CPC A61N5/1001, A61M37/0069Technology
- PHP
- MySQL
- Nginx
- WordPress
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Fee-for-service
- Team size
- 5 (previous snapshot 12)
- Recorded funding
- US$500k · Seed · Jun 2024
- Founded
- 2013 · about 13 years old
- Stage
- Seed
- Focus
- In vitro diagnostics tests, In-vitro diagnostic tests, Diversified, In-vitro diagnostics
Founders · 2
Norman SharplessCo-Founder
Natalia MitinCo-Founder & CEO
- Highest education
- Doctor of Philosophy · Bowling Green State University
Team & hiring signals
LinkedIn headcount62-10
LinkedIn followers392
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
- Revenue
- Not reported
- Revenue growth
- Not reported
- Revenue model
- Physical commerce
- Team size
- 4 (previous snapshot 6)
- Recorded funding
- US$6.45m · Series B · Dec 2020
- Founded
- 2014 · about 12 years old
- Stage
- Series B
- Focus
- Drugs, Diversified, Immuno oncology, Research services
Funding over time
US$6.45m across 2 disclosed equity rounds
Darker bars = larger roundsFounders · 1
Edward PatzCo-Founder & CEO
Investors · 4
- Duke UniversityFund
- Jeffery “TJ” HeymanAngel
- Paul FunkAngel
Team & hiring signals
LinkedIn headcount42-10
LinkedIn followers615
LinkedIn page Technology
- PHP
- MySQL
- Nginx
- WordPress
- jQuery
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Explore more lists: nearby cities and other sectors in North Carolina
165 more company lists you can search, plus the Radar directory pages for each place.
Life sciences in nearby cities
- Oakland33 life sciences companiesExplore on Radar
- San Jose110 life sciences companiesExplore on Radar
- Palo Alto165 life sciences companiesExplore on Radar
- Mountain View112 life sciences companiesExplore on Radar
- Santa Clara70 life sciences companiesExplore on Radar
- Sunnyvale123 life sciences companiesExplore on Radar
- San Mateo49 life sciences companiesExplore on Radar
- Redwood City107 life sciences companiesExplore on Radar
- Berkeley109 life sciences companiesExplore on Radar
- Santa Monica35 life sciences companiesExplore on Radar
- San Diego847 life sciences companiesExplore on Radar
- Los Angeles286 life sciences companiesExplore on Radar
Life sciences in other US cities
- New York City665 life sciences companiesExplore on Radar
- Chicago205 life sciences companiesExplore on Radar
- Austin221 life sciences companiesExplore on Radar
- Boston537 life sciences companiesExplore on Radar
- Miami106 life sciences companiesExplore on Radar
- Seattle247 life sciences companiesExplore on Radar
- Denver82 life sciences companiesExplore on Radar
- Atlanta133 life sciences companiesExplore on Radar
- Houston240 life sciences companiesExplore on Radar
- Dallas104 life sciences companiesExplore on Radar
- Philadelphia207 life sciences companiesExplore on Radar
- Washington435 life sciences companiesExplore on Radar
Other sectors in North Carolina
- Business Services Companies in North Carolina, United States 1,247
- Enterprise Applications Companies in North Carolina, United States 1,001
- Healthcare Companies in North Carolina, United States 827
- Consumer Companies in North Carolina, United States 676
- Real Estate and Construction Companies in North Carolina, United States 675
- Financial Services Companies in North Carolina, United States 526
- HealthTech Companies in North Carolina, United States 501
- Retail Companies in North Carolina, United States 487
- Consumer Goods Companies in North Carolina, United States 476
- Investment Industry Companies in North Carolina, United States 374
- Food and Agriculture Companies in North Carolina, United States 369
- FinTech Companies in North Carolina, United States 338
- High Tech Companies in North Carolina, United States 337
- Marketing Services Companies in North Carolina, United States 288
- Industrial Goods and Manufacturing Companies in North Carolina, United States 262
- Healthcare IT Companies in North Carolina, United States 238
- Media & Entertainment Companies in North Carolina, United States 221
- Food and Agriculture Tech Companies in North Carolina, United States 209
- Enterprise Infrastructure Companies in North Carolina, United States 204
- IT Services Companies in North Carolina, United States 200
- Energy Companies in North Carolina, United States 193
- Environment Companies in North Carolina, United States 180
- Sustainability Tech Companies in North Carolina, United States 180
- Real Estate and Construction Tech Companies in North Carolina, United States 176
- Education Companies in North Carolina, United States 174
- HRTech Companies in North Carolina, United States 166
- MarketingTech Companies in North Carolina, United States 164
- Auto Companies in North Carolina, United States 147
- Biopharma Outsourcing Companies in North Carolina, United States 146
- EdTech Companies in North Carolina, United States 143
- Transportation and Logistics Companies in North Carolina, United States 142
- Manufacturing Services Companies in North Carolina, United States 130
- Professional Consumer Services Companies in North Carolina, United States 128
- Chemicals and Materials Companies in North Carolina, United States 121
- Enterprise Software Companies in North Carolina, United States 120
- Travel and Hospitality Companies in North Carolina, United States 120
- Transportation and Logistics Tech Companies in North Carolina, United States 119
- HR Services Companies in North Carolina, United States 116
- Home Furnishing Products Companies in North Carolina, United States 114
- Telecom Companies in North Carolina, United States 113
- Finance & Accounting Services Companies in North Carolina, United States 109
- Energy Tech Companies in North Carolina, United States 107
- SaaS Companies in North Carolina, United States 103
- Auto Retail & Aftersales Companies in North Carolina, United States 102
- Services for Healthcare Providers Companies in North Carolina, United States 102
- Building Materials Companies in North Carolina, United States 101
- Environment Tech Companies in North Carolina, United States 100
- Auto Tech Companies in North Carolina, United States 98
- Internet of Things - Industry Applications Companies in North Carolina, United States 98
- Nonprofits Companies in North Carolina, United States 95
- Private Equity Funds Companies in North Carolina, United States 92
- Clinic Chains Companies in North Carolina, United States 91
- Investment Tech Companies in North Carolina, United States 91
- Facility Management Services Companies in North Carolina, United States 89
- Life Sciences Platforms and Tools Companies in North Carolina, United States 88
- Management Consulting Services Companies in North Carolina, United States 88
- Crop Tech Companies in North Carolina, United States 87
- Logistics Tech Companies in North Carolina, United States 87
- Legal Services Companies in North Carolina, United States 84
- Asset Management Companies in North Carolina, United States 83
- Sales Force Automation Companies in North Carolina, United States 82
- Real Estate Brokers Companies in North Carolina, United States 81
- Venture Capital Funds Companies in North Carolina, United States 81
- Life Sciences Tech Companies in North Carolina, United States 79
- Food & Beverage Products Companies in North Carolina, United States 78
- Rehabilitation and Long-Term Care Companies in North Carolina, United States 78
- Construction Contractors Companies in North Carolina, United States 76
- Cybersecurity Companies in North Carolina, United States 76
- Clinics Companies in North Carolina, United States 75
- Fashion Tech Companies in North Carolina, United States 75
- Insurance Distribution Companies in North Carolina, United States 74
- Waste & Water Management Companies in North Carolina, United States 74
- Semiconductors Companies in North Carolina, United States 74
- Real Estate & Infrastructure Developers Companies in North Carolina, United States 72
- K-12 EdTech Companies in North Carolina, United States 71
- Genomics Companies in North Carolina, United States 71
- Food Tech Companies in North Carolina, United States 70
- Sports Tech Companies in North Carolina, United States 69
- Travel and Hospitality Tech Companies in North Carolina, United States 69
- Banks Companies in North Carolina, United States 67
- Food Service Chains Companies in North Carolina, United States 65
- Unbundling of Craigslist Companies in North Carolina, United States 65
- Foundations Companies in North Carolina, United States 63
- Investment Banks Companies in North Carolina, United States 61
- Vertical SaaS Companies in North Carolina, United States 59
- Local Services Companies in North Carolina, United States 58
- Solar Energy Companies in North Carolina, United States 57
- Finance & Accounting Tech Companies in North Carolina, United States 55
- Manufacturing Tech Companies in North Carolina, United States 55
- E-Commerce Enablers Companies in North Carolina, United States 55
- Aerospace, Maritime and Defense Companies in North Carolina, United States 55
- Internet First Media Companies in North Carolina, United States 54
- Facility Management Tech Companies in North Carolina, United States 53
- Fitness & Wellness Tech Companies in North Carolina, United States 53
- Online Grocery Companies in North Carolina, United States 53
- Security & Surveillance Technology Companies in North Carolina, United States 52
- Gaming Companies in North Carolina, United States 51
- Real Estate Funds Companies in North Carolina, United States 51
- Business Intelligence Companies in North Carolina, United States 50
- Continued Learning Companies in North Carolina, United States 50
- Native AI Companies in North Carolina, United States 49
- Oncology Companies in North Carolina, United States 49
- Artificial Intelligence Companies in North Carolina, United States 48
- GRC Software Companies in North Carolina, United States 48
- Banking Tech Companies in North Carolina, United States 47
- Alcoholic Beverage Products Companies in North Carolina, United States 47
- B2C E-Commerce Companies in North Carolina, United States 47
- Insurance Carriers Companies in North Carolina, United States 46
- Neurology Companies in North Carolina, United States 45
- Property Management Tech Companies in North Carolina, United States 45
- B2B E-Commerce Companies in North Carolina, United States 44
- Home Healthcare Companies in North Carolina, United States 44
- Legal Tech Companies in North Carolina, United States 44
- Payments Companies in North Carolina, United States 43
- Wearable Technology Companies in North Carolina, United States 43
- Sports Services Companies in North Carolina, United States 43
- Enterprise Resource Planning Companies in North Carolina, United States 43
- Enterprise Collaboration Companies in North Carolina, United States 43
- Energy Efficiency Tech Companies in North Carolina, United States 42
- In Store Retail Tech Companies in North Carolina, United States 42
- Blockchain Technology Companies in North Carolina, United States 41
- Mobile Companies in North Carolina, United States 41
- SCM Software Companies in North Carolina, United States 41
- Chemicals and Materials Tech Companies in North Carolina, United States 40
- Services for Investment Industry Companies in North Carolina, United States 40
- Freight Forwarders Companies in North Carolina, United States 39
- K-12 Schools Companies in North Carolina, United States 38
- Service Providers to Banks Companies in North Carolina, United States 38
- Alternative Lending Companies in North Carolina, United States 36
- Hotels Companies in North Carolina, United States 36
- Higher Education Tech Companies in North Carolina, United States 35
- Telecom Operators Companies in North Carolina, United States 35
- Telecom Infrastructure Companies in North Carolina, United States 35
- Construction Tech Companies in North Carolina, United States 35
- Aerospace, Maritime and Defense Tech Companies in North Carolina, United States 35
- Auto Components Companies in North Carolina, United States 34
- InsurTech Companies in North Carolina, United States 34
- Cardiac and Vascular Disorders Companies in North Carolina, United States 33
- Orthopedics Companies in North Carolina, United States 33
- Beauty & Personal Care Products Companies in North Carolina, United States 32
- Big Data Analytics Companies in North Carolina, United States 32
No list matches. Try a shorter word.